n-methyl-3,4-methylenedioxyamphetamine has been researched along with amphetamine in 205 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (4.39) | 18.7374 |
| 1990's | 32 (15.61) | 18.2507 |
| 2000's | 63 (30.73) | 29.6817 |
| 2010's | 67 (32.68) | 24.3611 |
| 2020's | 34 (16.59) | 2.80 |
| Authors | Studies |
|---|---|
| Glennon, RA | 1 |
| Callaway, CW; Geyer, MA | 2 |
| Huang, XM; Johnson, MP; Nichols, DE | 1 |
| Culp, S; De Souza, EB; Zaczek, R | 1 |
| Evans, SM; Johanson, CE; Zacny, JP | 1 |
| Callaway, CW; Geyer, MA; Wing, LL | 1 |
| Abbate, GM; Black, CK; Schmidt, CJ; Taylor, VL | 1 |
| Gold, LH; Hubner, CB; Koob, GF | 1 |
| Gold, LH; Koob, GF | 1 |
| Glennon, RA; Misenheimer, BR | 1 |
| Brady, JF; Cho, AK; Di Stefano, EW | 1 |
| Johanson, CE; Kamien, JB; Schuster, CR; Woolverton, WL | 1 |
| Evans, SM; Johanson, CE | 1 |
| Nichols, DE; Steele, TD; Yim, GK | 1 |
| Fitzgerald, RL; Poklis, A; Ramos, JM | 1 |
| Nichols, DE; Oberlender, R | 1 |
| Cirimele, V; Kintz, P; Mangin, P; Tracqui, A | 1 |
| Fitzgerald, JL; Reid, JJ | 2 |
| Davies, KG; Neal, JW; Selmi, F; Sharma, RR | 1 |
| Dasgupta, A; Thompson, WC | 1 |
| Marona-Lewicka, D; Nichols, DE | 1 |
| Castagna, F; Ferrara, SD; Frison, G; Giorgetti, R; Tedeschi, L | 1 |
| Fitzgerald, RL; Hall, KV; Poklis, A; Saady, JJ | 1 |
| Barrett, PJ; Taylor, GT | 1 |
| Cadier, MA; Clarke, JA | 1 |
| Huang, X; Nichols, DE | 1 |
| Bennett, BA; Hollingsworth, CK; Wichems, CH | 1 |
| Frederick, SL; Galloway, G; Kornfeld, H; Shulgin, AT | 1 |
| Cox, DE; Williams, KR | 1 |
| Kauert, G; Röhrich, J | 1 |
| Schechter, MD | 1 |
| Crespi, D; Gobbi, M; Mennini, T | 1 |
| Baker, LE; Miller, ME; Sullivan, CL; Virden, TB | 1 |
| Fischer, K; Harrach, T; Kunkel, J; Pragst, F; Rothe, M; Spiegel, K | 1 |
| Dafters, RI; Lynch, E | 1 |
| Burden, PM; Christie, MJ; Johnston, GA; Lin, HQ | 1 |
| Christophersen, AS; Smith-Kielland, A | 1 |
| Jones, AL; Simpson, KJ | 1 |
| Christensen, HR | 1 |
| Christensen, HR; Hedetoft, C | 1 |
| Asari, D; Iravani, MM; Kruk, ZL; Patel, J; Wieczorek, WJ | 1 |
| Vollenweider, FX; Vollenweider-Scherpenhuyzen, MF | 1 |
| Dal Cason, TA | 1 |
| Martin, TL | 1 |
| Amara, SG; Arttamangkul, S; Bunzow, JR; Darland, T; Grandy, DK; Harrison, LM; Kennedy, JL; Magenis, RE; Olson, SB; Pasumamula, S; Quigley, DI; Sonders, MS; Suchland, KL; Zhang, G | 1 |
| Brehm, G; Sägmüller, B; Schneider, S; Schwarze, B | 1 |
| Booij, J; de Bruin, K; den Heeten, GJ; Gunning, B; Lavalaye, J; Reitsma, JB; Reneman, L; van Den Brink, W | 1 |
| Dams, R; De Leenheer, AP; De Letter, EA; Lambert, WE; Mortier, KA; Van Calenbergh, S | 1 |
| Byard, RW; Camilleri, AM; James, RA; Kostakis, C; Rodgers, NG | 1 |
| Smith, M | 1 |
| Ali, SF; Blough, B; Gough, B; Imam, SZ; Slikker, W | 1 |
| Barnett, DA; Ells, B; Guevremont, R; McCooeye, MA; Mester, Z; Purves, RW | 1 |
| Kovar, KA; Mayerhofer, A; Meyer, A; Schmidt, WJ | 1 |
| Kaa, E; Nielsen, E; Rollmann, D; Simonsen, KW | 1 |
| Cole, JC; Marsden, CA; O'Shea, E; Sumnall, HR | 1 |
| Cooper, DP; De Boeck, G; De Bruijn, EA; Maes, RA; Morris, M; Samyn, N; Wood, M | 1 |
| Huang, Z; Zhang, S | 1 |
| Daumann, J; Gouzoulis-Mayfrank, E; Schnell, K; Schnitker, R; Thron, A; Weidemann, J | 1 |
| de la Torre, R; Farré, M; Menoyo, E; Pichini, S; Poudevida, S; Pujadas, M; Zuccaro, P | 1 |
| de la Torre, R; Farré, M; Navarro, M; Pacifici, R; Pichini, S; Zuccaro, P | 1 |
| Daumann, J; Fischermann, T; Gouzoulis-Mayfrank, E; Heekeren, K; Thron, A | 1 |
| Dowgiert, J; Francescutti-Verbeem, D; Geddes, TJ; Kuhn, DM; Liu, X; Thomas, DM | 1 |
| Daumann, J; Fischermann, T; Gouzoulis-Mayfrank, E; Heekeren, K; Henke, K; Thron, A | 1 |
| Cole, JC; Sumnall, HR; Tyler, E; Wagstaff, GF | 1 |
| Hugel, J; Kalasinsky, KS; Kish, SJ | 1 |
| Chrostek Maj, J; Kamenczak, A; Kroch, S; Polewka, A; Szerszeń-Motyka, J | 1 |
| Biagioni, F; Busceti, CL; di Poggio, AB; Ferrucci, M; Fornai, F; Giusiani, M; Lazzeri, G; Lenzi, P; Natale, G; Paparelli, A; Ruggieri, S | 1 |
| De Boeck, G; Laloup, M; Maes, V; Ramaekers, J; Samyn, N; Tilman, G; Wallemacq, P | 1 |
| Burton, FC; Scott-Ham, M | 1 |
| Capuani, EM; Herzig, V; Kovar, KA; Schmidt, WJ | 1 |
| Arct-Danielak, D; Karpel, E; Kunsdorf-Wnuk, A; Musioł, E | 1 |
| Boehm, S; Dorostkar, MM; Hilber, B; Holy, M; Sandtner, W; Scholze, P; Singer, EA; Sitte, HH | 1 |
| Gudelsky, GA; Nair, SG | 1 |
| Dietzen, DJ; Koenig, JW; Moyer, TP; Saunders, AN; Turk, J; Woodworth, A | 1 |
| Lert, F; Obadia, Y; Peretti-Watel, P; Spire, B | 1 |
| Johansen, SS; Olsen, KH; Rasmussen, LB | 1 |
| Chen, DD; Fang, N; Liu, H; Meng, P; Wang, M | 1 |
| Bradley, M; Irvine, GH; Shah, HV | 1 |
| Clayton, H; Cole, JC; Field, M; Goudie, AJ; Sumnall, HR | 1 |
| Chandler, MD; Fisk, JE; Montgomery, C; Murphy, PN; Wareing, M | 1 |
| Martins, LF; Ramaekers, JG; Samyn, N; Wennig, R; Yegles, M | 1 |
| Brown, J; Edwards, M; McKone, E; Ward, J | 1 |
| de Win, MM; Jager, G; Kahn, RS; Ramsey, NF; Schilt, T; van den Brink, W; van der Tweel, I; van Ree, JM | 1 |
| Bernardi, G; Federici, M; Mercuri, NB; Natoli, S; Sebastianelli, L | 1 |
| Betti, L; Fabbrini, L; Fabiani, O; Giannaccini, G; Giusiani, M; Giusti, L; Lucacchini, A; Macchia, M; Martini, C; Mascia, G; Palego, L; Pirone, A | 1 |
| Camarasa, J; Chipana, C; Escubedo, E; García-Ratés, S; Pubill, D | 1 |
| de Win, MM; Jager, G; Koeter, MW; Ramsey, NF; Schilt, T; Schmand, B; van den Brink, W | 1 |
| Cassel, JC; Cosquer, B; Hamida, SB; Jones, BC; Kelche, C; Plute, E | 1 |
| Andersson, M; Beck, O; Gustavsson, E; Stephanson, N | 1 |
| Callaghan, PD; Clemens, KJ; Cornish, JL; Dawson, B; McGregor, IS; Thompson, MR | 1 |
| Charlton, S; Cole, JC; Field, M; Goudie, AJ; Loverseed, AC; Sumnall, HR | 1 |
| Kankaanpää, A; Kurling, S; Seppälä, T | 1 |
| Holmgren, A; Jones, AW; Kugelberg, FC | 1 |
| Jones, AW | 1 |
| Araújo, JR; Gonçalves, P; Martel, F | 1 |
| Cheong, JC; In, MK; Kim, JY; Kim, MK; Lee, JI | 1 |
| Johansen, SS; Jornil, J | 1 |
| Albelda, MT; Costa, R; Domènech, A; Frías, JC; García-España, E; Navarro, P; Ortí, E; Reviriego, F; Yunta, MJ | 1 |
| Bafile, E; Compagnone, D; Curini, R; D'Ascenzo, G; Romolo, FS; Sergi, M | 1 |
| Went, MJ; West, MJ | 1 |
| Chen, CY; Lin, KM | 1 |
| Campos, I; Costa, F; Gonçalves, P; Keating, E; Martel, F | 1 |
| Gawlikowski, T; Gomółka, E; Król, A | 1 |
| In, MK; Kim, JY; Lee, JI; Shin, SH | 1 |
| Gunn, J; Kriger, S; Terrell, AR | 1 |
| Fantegrossi, W; Howell, LL; McClung, J | 1 |
| Becker, J; Röhrich, J; Urban, R; Zörntlein, S | 1 |
| Bailly, E; Karolak, S; Levi, Y; Nefau, T; Solgadi, A | 1 |
| Barceló, D; de Alda, ML; Postigo, C | 1 |
| Li, H; Metcalfe, C; Rodayan, A; Tindale, K; Yargeau, V | 1 |
| Amos-Kroohs, R; Braun, AA; Grace, CE; Graham, DL; He, E; Schaefer, TL; Skelton, MR; Vorhees, CV; Williams, MT | 1 |
| Becker, B; Daumann, J; Gouzoulis-Mayfrank, E; Imperati, D; Koester, P; Tittgemeyer, M; Wagner, D | 1 |
| Brunt, TM; Niesink, RJ; Poortman, A; van den Brink, W | 1 |
| Arendt, M; Jensen, SO; Munk-Jørgensen, P; Sher, L | 1 |
| Beringer, K; Broadbear, JH; Tunstall, B | 1 |
| Choi, H; Chung, H; Chung, KH; In, S; Kim, J; Lee, S | 1 |
| Blacik, LJ; Kazarian, CM; Ntamack, AG; Romberg, RW; Snyder, JJ; Welsh, ER | 1 |
| Heikman, PK; Ojanperä, IA; Rasanen, IJ | 1 |
| Brown, JW; Dunne, JW; Fatovic, DM; Fatovich, DM; Lawn, ND; Lee, J | 1 |
| Goiny, M; Ichinose, F; Kehr, J; Nyberg, F; Sievertsson, T; Yoshitake, S; Yoshitake, T | 1 |
| Ben Hamida, S; Cassel, JC; de Vasconcelos, AP; Jones, BC; Mohamed, WM | 1 |
| Brunt, TM; Niesink, RJ | 1 |
| Hondebrink, L; Meijer, M; Meulenbelt, J; Rietjens, SJ; Westerink, RH | 1 |
| Kereszty, EM; Kovács, K; Tóth, AR | 1 |
| Csák, R; Faragó, R; Rácz, J; Vadász, V | 1 |
| Becker, B; Bender, K; Daumann, J; Gouzoulis-Mayfrank, E; Kabbasch, C; Koester, P; Wagner, D | 1 |
| Chen, C; Felgate, PD; Irvine, RJ; Kostakis, C; White, JM | 1 |
| Hrubá, L; Macúchová, E; Nová, E; Pometlová, M; Rokyta, R; Schutová, B; Šlamberová, R | 1 |
| Šlamberová, R; Yamamotová, A | 1 |
| Angoa-Pérez, M; Briggs, DI; Francescutti, DM; Kane, MJ; Kuhn, DM; Shah, MM; Sykes, CE; Thomas, DM | 1 |
| Barrot, M; Bockaert, J; Charnay, Y; Compan, V; Dusticier, N; Jean, A; Laurent, L; Neve, R; Nieoullon, A | 1 |
| Cela, R; Quintana, JB; Racamonde, I; Rodil, R | 1 |
| Burch, HJ; Clarke, EJ; Hubbard, AM; Scott-Ham, M | 1 |
| Bowman, B; Lasarow, A; Matzopoulos, R | 1 |
| Frau, L; Morelli, M; Plumitallo, A; Simola, N | 1 |
| Bastos, ML; Capela, JP; Carvalho, F; Costa, VM; da Costa Araújo, S; Fernandes, E; Nogueira, TB; Pereira, FC | 1 |
| Kelly, JP; McDonnell-Dowling, K | 1 |
| Forster, SL; Fulde, GW | 1 |
| Hrebíčková, I; Macúchová, E; Mikulecká, A; Nohejlová, K; Pometlová, M; Ševčíková, M; Šlamberová, R | 1 |
| Boels, D; Bretaudeau Deguigne, M; Bruneau, C; Harry, P; Le Roux, G; Lelièvre, B; Turcant, A | 1 |
| Bramness, JG; Harman, C; Reid, MJ; Røislien, J; Salvatore, S; Thomas, KV | 1 |
| Law, PY; Loh, HH; Xu, C | 1 |
| Baker, LE; Harvey, EL | 1 |
| Genzen, JR; Johnson-Davis, KL; Sadler, AJ | 1 |
| Edwards, H; Flavel, SC; Haberfield, M; Pearson-Dennett, V; Todd, G; White, JM | 1 |
| Beduwe, C; Brunt, TM; Bücheli, A; Martins, D; Nagy, C; Ugarte, M; Ventura Vilamala, M | 1 |
| Argente-García, A; Campíns-Falcó, P; Herráez-Hernández, R; Moliner-Martínez, Y; Verdú-Andrés, J | 1 |
| Bagnall, J; Evans, SE; Kasprzyk-Hordern, B | 1 |
| Cheron, G; Fogel, S; Lesage, F | 1 |
| García-Cabrerizo, R; García-Fuster, MJ | 1 |
| Baralla, E; Boatto, G; Briguglio, I; Burrai, L; Demontis, MP; Nieddu, M; Pasciu, V; Varoni, MV | 1 |
| Freeto, SM; LeQue, JJ; Ohouo, PY; Rosano, TG; Wood, M | 1 |
| Castiglioni, S; Gracia-Lor, E; Zuccato, E | 1 |
| Banks, ML; Negus, SS | 1 |
| Brunt, TM; van der Gouwe, D; van der Pol, P; van Laar, M | 1 |
| Downey, LA; Ford, TC; Parrott, AC; Samuels, AC; Tysse, B; Wilson, RP | 1 |
| Daumann, J; Gouzoulis-Mayfrank, E; Koester, P; Sauder, T; Wagner, D | 1 |
| Castiglioni, S; Gracia-Lor, E; Parabiaghi, A; Riva, F; Rousis, NI; Senta, I; Zuccato, E | 1 |
| Andreasen, MF; Christiansen, C; Christrup, LL; Hoegberg, LCG; Kongstad, KT; Soe, J; Staerk, D; Telving, R | 1 |
| Dolan, SB; Forster, MJ; Gatch, MB | 1 |
| Kahler-Venter, CP; Mothibe, ME; Osuch, E | 1 |
| Barceló, B; Busardò, FP; Dastis, M; Elorza, MÁ; Gomila, I; Moranta, C; Pastor, Y; Quesada, L; Torrents, A | 1 |
| Gonçalves, ILP; Kuca, K; Nepovimova, E; Neto, AFG; Neto, AMJC; Reis, AFVF; Santos, AS | 1 |
| Foppe, KS; Hammond-Weinberger, DR; Subedi, B | 1 |
| Barratt, MJ; Bruno, R; Burns, L; Peacock, A; Roxburgh, A; Sutherland, R | 1 |
| Highgate, Q; Schenk, S | 1 |
| Johansen, SS; Linnet, K; Nedahl, M | 1 |
| Lappin, JM; Sara, GE | 1 |
| Bourgogne, E; Delhotal-Landes, B; Gourlain, H; Labat, L; Leclercq, M; Mégarbane, B; Soichot, M | 1 |
| Mesihää, S; Ojanperä, I; Pelander, A; Rasanen, I | 1 |
| Amundsen, EJ; Baz-Lomba, JA; de Voogt, P; Emke, E; Goulding, N; Hall, W; Hickman, M; Jones, HE; Kuijpers, W; O'Brien, JW; Reid, M; Tscharke, BJ | 1 |
| Alygizakis, NA; Andrés-Costa, MJ; Bade, R; Bannwarth, A; Barron, LP; Baz-Lomba, JA; Been, F; Benaglia, L; Berset, JD; Bijlsma, L; Bodík, I; Brenner, A; Brock, AL; Burgard, DA; Castiglioni, S; Castrignanò, E; Celma, A; Christophoridis, CE; Covaci, A; de Voogt, P; Delémont, O; Devault, DA; Dias, MJ; Emke, E; Esseiva, P; Fatta-Kassinos, D; Fedorova, G; Fytianos, K; Gerber, C; González-Mariño, I; Grabic, R; Gracia-Lor, E; Grüner, S; Gunnar, T; Hapeshi, E; Heath, E; Helm, B; Hernández, F; Kankaanpaa, A; Karolak, S; Kasprzyk-Hordern, B; Krizman-Matasic, I; Lai, FY; Lechowicz, W; Lopes, A; López de Alda, M; López-García, E; Löve, ASC; Mastroianni, N; McEneff, GL; Montes, R; Munro, K; Nefau, T; O'Brien, JW; Oberacher, H; Oertel, R; Olafsdottir, K; Ort, C; Picó, Y; Plósz, BG; Polesel, F; Postigo, C; Quintana, JB; Ramin, P; Reid, MJ; Rice, J; Rodil, R; Salgueiro-González, N; Schubert, S; Senta, I; Simões, SM; Sremacki, MM; Styszko, K; Terzic, S; Thomaidis, NS; Thomas, KV; Tscharke, BJ; Udrisard, R; van Nuijs, ALN; Yargeau, V; Zuccato, E | 1 |
| Burgueño, MJ; Castro, MÁ; Mateos-Campos, R; Sánchez, S | 1 |
| Busardò, FP; Gottardi, M; Graziano, S; Malaca, S; Marchei, E; Pichini, S | 1 |
| Almeida, D; Castro, AL; Franco, JM; Sousa, L; Tarelho, S; Teixeira, HM | 1 |
| Bastos, ML; Carmo, H; Carvalho, F; Dias da Silva, D; Faria, AC; Silva, JP | 1 |
| Derlet, RW; Laurin, EG; Placone, TW; Richards, JR; van der Linden, MC; Wang, CG | 1 |
| Akgür, SA; Aydoğdu, M | 1 |
| Daviskiba, S; Dean, D; Kern, P; King, A; Reed, B; Rockhill, S; Vohra, V | 1 |
| Hess, C; Losacker, M; Röhrich, J; Schwarze, B; Staudt, S; Zörntlein, S | 1 |
| Been, F; Boucheron, T; de Voogt, P; Emke, E; Esseiva, P; Reymond, N; Ter Laak, T | 1 |
| Hartwig, S; Krumbiegel, F; Niebel, A; Pragst, F | 1 |
| Lee, WM; Li, CK; Wong, GF | 1 |
| Ducret, P; Hoener, MC; Kolaczynska, KE; Liechti, ME; Luethi, D; Trachsel, D | 1 |
| Heath, D; Heath, E; Verovšek, T | 1 |
| Bijlsma, L; Capela, R; Cela, R; Celma, A; Estévez-Danta, A; Hernández, F; Lertxundi, U; Matias, J; Montes, R; Orive, G; Prieto, A; Quintana, JB; Rodil, R; Santos, MM | 1 |
| Bastiani, MF; da Silva Moreira, IC; do Nascimento, CA; Hahn, RZ; Linden, R; Lizot, LLF; Meireles, YF; Schneider, A; Viana, MF | 1 |
| Guzel, EY | 1 |
| Christoffersen, DJ; Hermansen, SK | 1 |
| Bouazzati, M; Di Fazio, V; Rubbens, J; Samyn, N; Wille, SMR | 1 |
| Fatta-Kassinos, D; Michael, C; Mina, C; Mina, T; Psichoudaki, M; Savvidou, M | 1 |
| Drummer, OH; Pope, JD; Schneider, HG | 1 |
| Chen, H; Di, B; Hu, J; Ji, J; Li, B; Liu, M; Liu, W | 1 |
| Cunha, RL; de Oliveira, AL; do Desterro Cunha, S; Maldaner, AO; Oliveira, CDSL; Pereira, PAP | 1 |
| Bello, D; Luo, J; Pagsuyoin, S | 1 |
| Haghparast, A; Karimi-Haghighi, S; Mahmoudi, M; Mozafari, R; Sayehmiri, F | 1 |
| Campo, J; Picó, Y; Sadutto, D; Vera-Herrera, L; Vitale, D | 1 |
| Ahel, M; Gonzalez-Mariño, I; Kostanjevecki, P; Krizman-Matasic, I; Mikac, I; Quintana, JB; Rodil, R; Senta, I; Terzic, S | 1 |
| Cruz, SL; Paz-Ramos, MI; Violante-Soria, V | 1 |
| Baumgartner, MR; Fischer, SKM; Müller, TJ; Mutschler, J; Perlov, E; Seifritz, E; Soyka, M; Tschudi, L | 1 |
| Bartolli, M; Eysseric-Guérin, H; Jourdil, JF; Stanke-Labesque, F; Vial, S; Willeman, T | 1 |
| Choe, S; Kang, S; Kim, J; Lee, N; Park, M; Park, Y; Song, J; Yum, H | 1 |
| Bencomo-Cruz, M; Cruz, SL; Fleiz-Bautista, C; Medina-Mora, ME; Vázquez-Quiroz, F | 1 |
14 review(s) available for n-methyl-3,4-methylenedioxyamphetamine and amphetamine
| Article | Year |
|---|---|
Review article: mechanisms and management of hepatotoxicity in ecstasy (MDMA) and amphetamine intoxications.
Topics: Amphetamine; Humans; Liver; Liver Transplantation; N-Methyl-3,4-methylenedioxyamphetamine | 1999 |
[Amphetamine, ecstasy and cocaine. Clinical aspects of acute poisoning].
Topics: Amphetamine; Amphetamine-Related Disorders; Central Nervous System Stimulants; Cocaine; Cocaine-Related Disorders; Drug Overdose; Emergencies; Hallucinogens; Humans; Illicit Drugs; N-Methyl-3,4-methylenedioxyamphetamine; Poisoning | 1999 |
[Emergencies due to drug abuse].
Topics: Adrenergic Uptake Inhibitors; Amphetamine; Cocaine; Diagnosis, Differential; Emergency Treatment; Germany; Heroin; Humans; Illicit Drugs; N-Methyl-3,4-methylenedioxyamphetamine; Narcotics; Substance-Related Disorders | 2000 |
Clinical pharmacokinetics of amfetamine and related substances: monitoring in conventional and non-conventional matrices.
Topics: Amphetamine; Central Nervous System Stimulants; Designer Drugs; Drug Interactions; Drug Monitoring; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Substance Abuse Detection | 2004 |
Health consequences of illegal drug use.
Topics: Amphetamine; Depressive Disorder; Health Status; Hepatitis C; Humans; Illicit Drugs; Marijuana Abuse; N-Methyl-3,4-methylenedioxyamphetamine; Psychotic Disorders; Substance Abuse, Intravenous; Substance-Related Disorders | 2009 |
MDMA: interactions with other psychoactive drugs.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Caffeine; Cannabis; Central Nervous System Depressants; Cocaine; Drug Interactions; Ethanol; Hallucinogens; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Nicotine; Psychotropic Drugs; Substance-Related Disorders | 2011 |
The Drug Information and Monitoring System (DIMS) in the Netherlands: implementation, results, and international comparison.
Topics: Amphetamine; Central Nervous System Stimulants; Cocaine; Hallucinogens; Humans; Illicit Drugs; N-Methyl-3,4-methylenedioxyamphetamine; Netherlands; Substance Abuse Detection | 2011 |
Sources of variation in the design of preclinical studies assessing the effects of amphetamine-type stimulants in pregnancy and lactation.
Topics: Amphetamine; Amphetamines; Animals; Animals, Newborn; Central Nervous System Stimulants; Disease Models, Animal; Female; Lactation; Methamphetamine; Mice; N-Methyl-3,4-methylenedioxyamphetamine; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley; Rats, Wistar; Research Design | 2015 |
The impact of amphetamine-type stimulants on emergency services.
Topics: Acute Disease; Aggression; Amphetamine; Amphetamine-Related Disorders; Anxiety; Central Nervous System Stimulants; Delusions; Depression; Drug Overdose; Emergency Service, Hospital; Hallucinations; Humans; Illicit Drugs; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Paranoid Disorders; Sleep Initiation and Maintenance Disorders; Suicidal Ideation | 2015 |
Effects of addictive drugs on adult neural stem/progenitor cells.
Topics: Adult Stem Cells; Amphetamine; Analgesics, Opioid; Animals; Cannabinoids; Cell Proliferation; Central Nervous System Stimulants; Cocaine; Ethanol; Ganglionic Stimulants; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Neural Stem Cells; Neurogenesis; Neurotransmitter Agents; Nicotine; Substance-Related Disorders | 2016 |
Psychostimulant use and the brain.
Topics: Amphetamine; Amphetamine-Related Disorders; Brain; Central Nervous System Stimulants; Cocaine; Cocaine-Related Disorders; Cognitive Dysfunction; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Parkinson Disease, Secondary; Psychoses, Substance-Induced; Seizures; Stroke | 2019 |
Drinking to death: Hyponatraemia induced by synthetic phenethylamines.
Topics: Alcohol Drinking; Alkaloids; Amphetamine; Drinking; Humans; Hyponatremia; Illicit Drugs; N-Methyl-3,4-methylenedioxyamphetamine; Neurophysins; Phenethylamines; Protein Precursors; Vasopressins | 2020 |
Endocannabinoid system as a therapeutic target for psychostimulants relapse: A systematic review of preclinical studies.
Topics: Amphetamine; Animals; Cannabinoid Receptor Antagonists; Central Nervous System Stimulants; Cocaine; Endocannabinoids; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Receptors, Cannabinoid; Recurrence | 2023 |
Amphetamine-type Stimulants: Novel Insights into their Actions and use Patterns.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Central Nervous System Stimulants; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine | 2023 |
5 trial(s) available for n-methyl-3,4-methylenedioxyamphetamine and amphetamine
| Article | Year |
|---|---|
Neural correlates of working memory in pure and polyvalent ecstasy (MDMA) users.
Topics: Adult; Amphetamine; Brain; Central Nervous System Stimulants; Cognition; Female; Hallucinogens; Humans; Magnetic Resonance Imaging; Male; Marijuana Abuse; Memory, Short-Term; N-Methyl-3,4-methylenedioxyamphetamine; Psychomotor Performance; Reaction Time; Substance-Related Disorders | 2003 |
Neural mechanisms of working memory in ecstasy (MDMA) users who continue or discontinue ecstasy and amphetamine use: evidence from an 18-month longitudinal functional magnetic resonance imaging study.
Topics: Adult; Amphetamine; Cannabis; Central Nervous System Stimulants; Cerebral Cortex; Dose-Response Relationship, Drug; Female; Hallucinogens; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Memory, Short-Term; N-Methyl-3,4-methylenedioxyamphetamine; Neuropsychological Tests; Oxygen; Reaction Time; Regression Analysis; Substance-Related Disorders | 2004 |
Validation of an ELISA-based screening assay for the detection of amphetamine, MDMA and MDA in blood and oral fluid.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Chromatography, Liquid; Dose-Response Relationship, Drug; Double-Blind Method; Enzyme-Linked Immunosorbent Assay; Forensic Medicine; Gas Chromatography-Mass Spectrometry; Hallucinogens; Humans; Mass Spectrometry; N-Methyl-3,4-methylenedioxyamphetamine; ROC Curve; Saliva; Sensitivity and Specificity; Substance Abuse Detection | 2005 |
A long-term ecstasy-related change in visual perception.
Topics: Adult; Amphetamine; Drug Synergism; Female; Hallucinogens; Humans; Male; N-Methyl-3,4-methylenedioxyamphetamine; Occipital Lobe; Visual Perception | 2007 |
Memory-related hippocampal functioning in ecstasy and amphetamine users: a prospective fMRI study.
Topics: Adolescent; Adult; Amphetamine; Drug Users; Female; Follow-Up Studies; Hippocampus; Humans; Magnetic Resonance Imaging; Male; Memory; N-Methyl-3,4-methylenedioxyamphetamine; Prospective Studies; Young Adult | 2013 |
186 other study(ies) available for n-methyl-3,4-methylenedioxyamphetamine and amphetamine
| Article | Year |
|---|---|
The 2014 Philip S. Portoghese Medicinal Chemistry Lectureship: The "Phenylalkylaminome" with a Focus on Selected Drugs of Abuse.
Topics: Animals; Central Nervous System Stimulants; Chemistry, Pharmaceutical; Dopamine; Drug Discovery; Hallucinogens; Humans; Illicit Drugs; Norepinephrine; Phenethylamines; Psychotropic Drugs; Receptors, Serotonin; Serotonin | 2017 |
Stimulant effects of 3,4-methylenedioxymethamphetamine in the nucleus accumbens of rat.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Animals; Behavior, Animal; Corpus Striatum; Fluoxetine; Male; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Nucleus Accumbens; Rats; Rats, Inbred Strains | 1992 |
Tolerance and cross-tolerance to the activating effects of 3,4-methylenedioxymethamphetamine and a 5-hydroxytryptamine1B agonist.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Animals; Behavior, Animal; Brain; Drug Interactions; Drug Tolerance; Indoles; Male; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley; Serotonin Receptor Agonists | 1992 |
Serotonin neurotoxicity in rats after combined treatment with a dopaminergic agent followed by a nonneurotoxic 3,4-methylenedioxymethamphetamine (MDMA) analogue.
Topics: 3,4-Dihydroxyphenylacetic Acid; 3,4-Methylenedioxyamphetamine; Amphetamine; Animals; Brain; Dopamine; Dopamine Agents; Homovanillic Acid; Hydroxyindoleacetic Acid; Indans; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Serotonin | 1991 |
Intrasynaptosomal sequestration of [3H]amphetamine and [3H]methylenedioxyamphetamine: characterization suggests the presence of a factor responsible for maintaining sequestration.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Amphetamines; Animals; Brain; Cell Fractionation; Designer Drugs; Digitonin; Kinetics; Male; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Inbred Strains; Synaptosomes; Thermodynamics | 1990 |
Three-choice discrimination among (+)-amphetamine, fenfluramine and saline in pigeons.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Animals; Columbidae; Discrimination, Psychological; Female; Fenfluramine; Generalization, Stimulus; N-Methyl-3,4-methylenedioxyamphetamine; Sodium Chloride | 1990 |
Serotonin release contributes to the locomotor stimulant effects of 3,4-methylenedioxymethamphetamine in rats.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Amphetamines; Animals; Dose-Response Relationship, Drug; Drug Interactions; Fenclonine; Fluoxetine; Gait; Injections, Subcutaneous; Male; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Inbred Strains; Serotonin | 1990 |
Selective 5-hydroxytryptamine2 receptor antagonists protect against the neurotoxicity of methylenedioxymethamphetamine in rats.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Animals; Brain; Cerebral Cortex; Dopamine; Hippocampus; Male; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Inbred Strains; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Tryptophan Hydroxylase | 1990 |
A role for the mesolimbic dopamine system in the psychostimulant actions of MDMA.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Amphetamines; Animals; Desipramine; Dopamine; Dose-Response Relationship, Drug; Hydroxydopamines; Male; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Nucleus Accumbens; Oxidopamine; Psychotropic Drugs; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Serotonin; Septal Nuclei | 1989 |
MDMA produces stimulant-like conditioned locomotor activity.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Amphetamines; Animals; Central Nervous System Stimulants; Cocaine; Conditioning, Operant; Male; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Inbred Strains | 1989 |
Stimulus effects of N-monoethyl-1-(3,4-methylenedioxyphenyl)-2-aminopropane (MDE) and N-hydroxy-1-(3,4-methylenedioxyphenyl)-2-aminopropane (N-OH MDA) in rats trained to discriminate MDMA from saline.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Amphetamines; Animals; Discrimination, Psychological; Dose-Response Relationship, Drug; Generalization, Stimulus; Male; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Inbred Strains | 1989 |
Spectral and inhibitory interactions of (+/-)-3,4-methylenedioxyamphetamine (MDA) and (+/-)-3,4-methylenedioxymethamphetamine (MDMA) with rat hepatic microsomes.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Amphetamines; Animals; Benzphetamine; Cytochrome P-450 Enzyme System; Kinetics; Male; Methamphetamine; Methimazole; Microsomes, Liver; N-Methyl-3,4-methylenedioxyamphetamine; NADP; Oxidoreductases, N-Demethylating; Rats; Spectrophotometry | 1986 |
The effects of (+/-)-methylenedioxymethamphetamine and (+/-)-methylenedioxyamphetamine in monkeys trained to discriminate (+)-amphetamine from saline.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Amphetamines; Animals; Avoidance Learning; Discrimination Learning; Discrimination, Psychological; Dose-Response Relationship, Drug; Female; Food; Macaca mulatta; Male; N-Methyl-3,4-methylenedioxyamphetamine | 1986 |
Discriminative stimulus properties of (+/-)-3,4-methylenedioxymethamphetamine and (+/-)-3,4-methylenedioxyamphetamine in pigeons.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Amphetamines; Animals; Columbidae; Discrimination Learning; Discrimination, Psychological; N-Methyl-3,4-methylenedioxyamphetamine | 1986 |
Stereochemical effects of 3,4-methylenedioxymethamphetamine (MDMA) and related amphetamine derivatives on inhibition of uptake of [3H]monoamines into synaptosomes from different regions of rat brain.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Amphetamines; Animals; Biological Transport; Corpus Striatum; Depression, Chemical; DOM 2,5-Dimethoxy-4-Methylamphetamine; Dopamine; Hippocampus; Hypothalamus; Male; N-Methyl-3,4-methylenedioxyamphetamine; Norepinephrine; Rats; Rats, Inbred Strains; Serotonin; Stereoisomerism; Synaptosomes | 1987 |
MDMA and MDA cross reactivity observed with Abbott TDx amphetamine/methamphetamine reagents.
Topics: 3,4-Methylenedioxyamphetamine; Adult; Amphetamine; Amphetamines; Cross Reactions; Female; Fluorescence Polarization; Gas Chromatography-Mass Spectrometry; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Reagent Kits, Diagnostic | 1988 |
Drug discrimination studies with MDMA and amphetamine.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Amphetamines; Animals; Discrimination Learning; DOM 2,5-Dimethoxy-4-Methylamphetamine; Lysergic Acid Diethylamide; Male; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Inbred Strains; Stereoisomerism; Structure-Activity Relationship | 1988 |
Simultaneous determination of amphetamine, methamphetamine, 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine in human hair by gas chromatography-mass spectrometry.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Gas Chromatography-Mass Spectrometry; Hair; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Reproducibility of Results; Substance-Related Disorders | 1995 |
Sympathomimetic actions of methylenedioxymethamphetamine in rat and rabbit isolated cardiovascular tissues.
Topics: Amphetamine; Animals; Desipramine; Female; Heart Rate; In Vitro Techniques; Male; N-Methyl-3,4-methylenedioxyamphetamine; Norepinephrine; Rabbits; Rats; Rats, Sprague-Dawley; Stimulation, Chemical; Sympathomimetics | 1994 |
Intracerebral haemorrhage due to amphetamine abuse: report of two cases with underlying arteriovenous malformations.
Topics: Adult; Amphetamine; Cerebral Cortex; Cerebral Hemorrhage; Female; Humans; Intracranial Arteriovenous Malformations; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Substance-Related Disorders | 1995 |
Microwave-induced rapid preparation of fluoro-derivatives of amphetamine, methamphetamine, and 3,4-methylenedioxymethamphetamine for GC-MS confirmation assays.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Calibration; Designer Drugs; Fluorides; Gas Chromatography-Mass Spectrometry; Methamphetamine; Microwaves; N-Methyl-3,4-methylenedioxyamphetamine; Phentermine | 1994 |
Behavioral effects of the highly selective serotonin releasing agent 5-methoxy-6-methyl-2-aminoindan.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Animals; Behavior, Animal; Discrimination Learning; Dose-Response Relationship, Drug; Indans; Male; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley; Serotonin Antagonists; Stereoisomerism | 1994 |
Simultaneous identification of amphetamine and its derivatives in urine using HPLC-UV.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Chromatography, High Pressure Liquid; Gas Chromatography-Mass Spectrometry; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Substance Abuse Treatment Centers; Substance-Related Disorders; Ultraviolet Rays | 1993 |
Interactions of methylenedioxymethamphetamine with monoamine transmitter release mechanisms in rat brain slices.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Animals; Biogenic Monoamines; Brain; Calcium; Electric Stimulation; Female; In Vitro Techniques; Male; N-Methyl-3,4-methylenedioxyamphetamine; Neurotransmitter Uptake Inhibitors; Pargyline; Rats; Rats, Sprague-Dawley; Reserpine | 1993 |
EMIT-d.a.u. monoclonal amphetamine/methamphetamine assay. II. Detection of methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA).
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Animals; Cross Reactions; Designer Drugs; Gas Chromatography-Mass Spectrometry; Immunoassay; Injections, Intravenous; Male; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Sensitivity and Specificity; Stereoisomerism | 1993 |
'Ecstasy' ingestion: a case report of severe complications.
Topics: 3,4-Methylenedioxyamphetamine; Acute Kidney Injury; Adult; Amphetamine; Designer Drugs; Disseminated Intravascular Coagulation; Humans; Liver; Male; N-Methyl-3,4-methylenedioxyamphetamine; Rhabdomyolysis; Substance-Related Disorders | 1993 |
Ecstasy and Whizz at a rave resulting in a major burn plus complications.
Topics: 3,4-Methylenedioxyamphetamine; Adult; Amphetamine; Burns; Designer Drugs; Drug Overdose; Humans; Male; N-Methyl-3,4-methylenedioxyamphetamine; Substance-Related Disorders | 1993 |
5-HT2 receptor-mediated potentiation of dopamine synthesis and central serotonergic deficits.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Amphetamines; Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Hippocampus; Hydrazines; Indans; Male; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists | 1993 |
Release of serotonin induced by 3,4-methylenedioxymethamphetamine (MDMA) and other substituted amphetamines in cultured fetal raphe neurons: further evidence for calcium-independent mechanisms of release.
Topics: Amphetamine; Animals; Calcium; Cells, Cultured; Dose-Response Relationship, Drug; Fenfluramine; N-Methyl-3,4-methylenedioxyamphetamine; Potassium Chloride; Raphe Nuclei; Rats; Serotonin | 1995 |
Amphetamine, not MDMA, is associated with intracranial hemorrhage.
Topics: Amphetamine; Central Nervous System Stimulants; Cerebral Hemorrhage; Drug Overdose; Female; Hallucinogens; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Substance-Related Disorders | 1995 |
"ADAM' or "EVE'?--a toxicological conundrum.
Topics: 3,4-Methylenedioxyamphetamine; Adolescent; Adult; Amphetamine; Female; Homicide; Humans; Male; N-Methyl-3,4-methylenedioxyamphetamine | 1996 |
Concentrations of delta 9-tetrahydrocannabinol, cocaine and 6-monoacetylmorphine in hair of drug abusers.
Topics: 3,4-Methylenedioxyamphetamine; Accidents, Traffic; Amphetamine; Cocaine; Crime; Designer Drugs; Dronabinol; Expert Testimony; Gas Chromatography-Mass Spectrometry; Hair; Heroin Dependence; Humans; Illicit Drugs; Marijuana Abuse; Morphine Derivatives; N-Methyl-3,4-methylenedioxyamphetamine; Opioid-Related Disorders; Psychotropic Drugs; Sensitivity and Specificity | 1996 |
Drug-drug discrimination: stimulus properties of drugs of abuse upon a serotonergic-dopaminergic continuum.
Topics: Amphetamine; Animals; Discrimination, Psychological; Dopamine; Dopamine Agonists; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Generalization, Stimulus; Lysergic Acid Diethylamide; Male; N-Methyl-3,4-methylenedioxyamphetamine; Norfenfluramine; Propiophenones; Rats; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Agents; Serotonin Receptor Agonists; Substance-Related Disorders; Tetrahydronaphthalenes; Time Factors | 1997 |
Carrier-dependent and Ca(2+)-dependent 5-HT and dopamine release induced by (+)-amphetamine, 3,4-methylendioxymethamphetamine, p-chloroamphetamine and (+)-fenfluramine.
Topics: Amphetamine; Animals; Calcium; Carrier Proteins; Dopamine; Fenfluramine; Male; Methiothepin; N-Methyl-3,4-methylenedioxyamphetamine; Neurotransmitter Uptake Inhibitors; p-Chloroamphetamine; Rats; Rats, Sprague-Dawley; Serotonin | 1997 |
Time course analysis of the discriminative stimulus effects of the optical isomers of 3,4-methylenedioxymethamphetamine (MDMA).
Topics: Amphetamine; Animals; Discrimination, Psychological; Dose-Response Relationship, Drug; Hallucinogens; Male; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley; Stereoisomerism; Time Factors | 1997 |
Hair concentrations and self-reported abuse history of 20 amphetamine and ecstasy users.
Topics: Adolescent; Adult; Amphetamine; Baths; Chromatography, High Pressure Liquid; Female; Gas Chromatography-Mass Spectrometry; Hair; Hair Color; Hallucinogens; Humans; Male; N-Methyl-3,4-methylenedioxyamphetamine; Substance Abuse Detection; Substance-Related Disorders; Time Factors | 1997 |
Persistent loss of thermoregulation in the rat induced by 3,4-methylenedioxymethamphetamine (MDMA or "Ecstasy") but not by fenfluramine.
Topics: Amphetamine; Animals; Body Temperature Regulation; Dopamine Agents; Female; Fenfluramine; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Wistar; Serotonin Agents | 1998 |
The anxiogenic-like and anxiolytic-like effects of MDMA on mice in the elevated plus-maze: a comparison with amphetamine.
Topics: Amphetamine; Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Diazepam; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Hallucinogens; Male; Mice; N-Methyl-3,4-methylenedioxyamphetamine | 1999 |
[Ecstasy and related drugs in biological materials].
Topics: Amphetamine; Amphetamine-Related Disorders; Drug Overdose; Hallucinogens; Humans; Immunologic Techniques; Immunologic Tests; N-Methyl-3,4-methylenedioxyamphetamine | 1999 |
[Poisoning with central nervous system stimulants. Amphetamine, ecstasy, cocaine and gamma-hydroxybutyrate].
Topics: Amphetamine; Amphetamine-Related Disorders; Cocaine; Cocaine-Related Disorders; Denmark; Drug Overdose; Hallucinogens; Humans; Illicit Drugs; N-Methyl-3,4-methylenedioxyamphetamine; Sodium Oxybate; Substance-Related Disorders | 1999 |
Direct effects of 3,4-methylenedioxymethamphetamine (MDMA) on serotonin or dopamine release and uptake in the caudate putamen, nucleus accumbens, substantia nigra pars reticulata, and the dorsal raphé nucleus slices.
Topics: Amphetamine; Animals; Brain; Caudate Nucleus; Dopamine; Electric Stimulation; Electrochemistry; In Vitro Techniques; Injections, Jet; Male; N-Methyl-3,4-methylenedioxyamphetamine; Nucleus Accumbens; Raphe Nuclei; Rats; Rats, Wistar; Serotonin; Substantia Nigra | 2000 |
A re-examination of the mono-methoxy positional ring isomers of amphetamine, methamphetamine and phenyl-2-propanone.
Topics: Acetone; Amphetamine; Amphetamines; Cause of Death; Chemistry, Pharmaceutical; Forensic Medicine; Gas Chromatography-Mass Spectrometry; Hallucinogens; Humans; Isomerism; Magnetic Resonance Spectroscopy; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Spectrophotometry, Infrared; Substance Abuse Detection; United States | 2001 |
Three cases of fatal paramethoxyamphetamine overdose.
Topics: Adolescent; Adult; Amphetamine; Amphetamines; Autopsy; Central Nervous System Stimulants; Chromatography, Gas; Drug Overdose; Female; Femoral Artery; Humans; Male; Myocardium; N-Methyl-3,4-methylenedioxyamphetamine | 2001 |
Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor.
Topics: Amino Acid Sequence; Amphetamine; Animals; Catecholamines; Chromosome Mapping; Chromosomes, Human, Pair 6; Cloning, Molecular; Dopamine Agents; Humans; Lysergic Acid Diethylamide; Molecular Sequence Data; N-Methyl-3,4-methylenedioxyamphetamine; Neurotransmitter Agents; Rats; Receptors, Biogenic Amine; Sequence Homology, Amino Acid; Serotonin Agents; Subcellular Fractions; Tumor Cells, Cultured | 2001 |
Application of SERS spectroscopy to the identification of (3,4-methylenedioxy)amphetamine in forensic samples utilizing matrix stabilized silver halides.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Illicit Drugs; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Spectrum Analysis, Raman | 2001 |
Use of amphetamine by recreational users of ecstasy (MDMA) is associated with reduced striatal dopamine transporter densities: a [123I]beta-CIT SPECT study--preliminary report.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Amphetamine; Analysis of Variance; Cocaine; Confidence Intervals; Corpus Striatum; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Female; Humans; Iodine Radioisotopes; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; N-Methyl-3,4-methylenedioxyamphetamine; Nerve Tissue Proteins; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2002 |
Determination of paramethoxyamphetamine and other amphetamine-related designer drugs by liquid chromatography/sonic spray ionization mass spectrometry.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Amphetamines; Chromatography, High Pressure Liquid; Designer Drugs; Forensic Medicine; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization | 2002 |
Death and paramethoxyamphetamine -- an evolving problem.
Topics: Adolescent; Adult; Amphetamine; Amphetamines; Fatal Outcome; Hallucinogens; Humans; Male; N-Methyl-3,4-methylenedioxyamphetamine | 2002 |
Street drug roulette continues.
Topics: Amphetamine; Amphetamines; Central Nervous System Stimulants; Emergency Medical Technicians; Hallucinogens; Humans; Illicit Drugs; Massachusetts; N-Methyl-3,4-methylenedioxyamphetamine; Substance-Related Disorders | 2002 |
Comparative effects of substituted amphetamines (PMA, MDMA, and METH) on monoamines in rat caudate: a microdialysis study.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamine; Amphetamines; Animals; Caudate Nucleus; Dopamine; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Methamphetamine; Microdialysis; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley; Serotonin | 2002 |
Quantitation of amphetamine, methamphetamine, and their methylenedioxy derivatives in urine by solid-phase microextraction coupled with electrospray ionization-high-field asymmetric waveform ion mobility spectrometry-mass spectrometry.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Central Nervous System Stimulants; Hallucinogens; Humans; Indicators and Reagents; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Spectrometry, Mass, Electrospray Ionization; Substance Abuse Detection | 2002 |
Rewarding effects of the optical isomers of 3,4-methylenedioxy-methylamphetamine ('Ecstasy') and 3,4-methylenedioxy-ethylamphetamine ('Eve') measured by conditioned place preference in rats.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Animals; Central Nervous System Stimulants; Choice Behavior; Conditioning, Operant; Hallucinogens; Isomerism; Male; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley; Reward; Social Isolation | 2002 |
Narcotics at street level in Denmark. A prospective investigation from 1995 to 2000.
Topics: Amphetamine; Analysis of Variance; Cocaine; Denmark; Drug Contamination; Drug Packaging; Hallucinogens; Heroin; Humans; Illicit Drugs; N-Methyl-3,4-methylenedioxyamphetamine; Narcotics; Prospective Studies; Substance-Related Disorders | 2003 |
Effects of MDMA exposure on the conditioned place preference produced by other drugs of abuse.
Topics: Amphetamine; Analysis of Variance; Animals; Behavior, Animal; Brain; Cocaine; Conditioning, Psychological; Drug Interactions; Ethanol; Hallucinogens; Heroin; Humans; Male; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Reward | 2003 |
Development of a rapid and sensitive method for the quantitation of amphetamines in human plasma and oral fluid by LC-MS-MS.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Amphetamines; Central Nervous System Stimulants; Chromatography, High Pressure Liquid; Chromatography, Liquid; Ephedrine; Humans; Mass Spectrometry; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Reproducibility of Results; Saliva; Substance Abuse Detection | 2003 |
Confirmation of amphetamine, methamphetamine, MDA and MDMA in urine samples using disk solid-phase extraction and gas chromatography-mass spectrometry after immunoassay screening.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Gas Chromatography-Mass Spectrometry; Immunoassay; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine | 2003 |
Development and validation of a gas chromatography-mass spectrometry assay for hair analysis of amphetamine, methamphetamine and methylenedioxy derivatives.
Topics: Amphetamine; Gas Chromatography-Mass Spectrometry; Hair; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Reproducibility of Results; Sensitivity and Specificity | 2003 |
Microglial activation is a pharmacologically specific marker for the neurotoxic amphetamines.
Topics: Amphetamine; Analysis of Variance; Animals; Blotting, Western; Cell Count; Corpus Striatum; Dopamine Agents; Female; Glial Fibrillary Acidic Protein; Immunohistochemistry; Lectins; Methamphetamine; Mice; Mice, Inbred C57BL; Microglia; N-Methyl-3,4-methylenedioxyamphetamine; p-Chloroamphetamine | 2004 |
Memory-related hippocampal dysfunction in poly-drug ecstasy (3,4-methylenedioxymethamphetamine) users.
Topics: Adult; Amphetamine; Brain Mapping; Cannabis; Female; Hallucinogens; Hippocampus; Humans; Magnetic Resonance Imaging; Male; Memory Disorders; N-Methyl-3,4-methylenedioxyamphetamine; Neuropsychological Tests; Oxygen; Reaction Time; Substance-Related Disorders | 2005 |
A behavioural economic analysis of alcohol, amphetamine, cocaine and ecstasy purchases by polysubstance misusers.
Topics: Adolescent; Adult; Alcoholic Beverages; Amphetamine; Analysis of Variance; Choice Behavior; Cocaine; Female; Humans; Male; N-Methyl-3,4-methylenedioxyamphetamine; Substance-Related Disorders | 2004 |
Use of MDA (the "love drug") and methamphetamine in Toronto by unsuspecting users of ecstasy (MDMA).
Topics: 3,4-Methylenedioxyamphetamine; Adult; Amphetamine; Canada; Cocaine; Dopamine Uptake Inhibitors; Drug Contamination; Female; Forensic Medicine; Gas Chromatography-Mass Spectrometry; Hair; Hallucinogens; Humans; Illicit Drugs; Male; Methamphetamine; Molecular Structure; N-Methyl-3,4-methylenedioxyamphetamine; Phencyclidine | 2004 |
[Assessment of disorders after chronic psychoactive drug abuse in patients hospitalized in detoxification units].
Topics: Adolescent; Adult; Amphetamine; Amphetamine-Related Disorders; Cannabis; Cocaine; Cocaine-Related Disorders; Female; Hospitalization; Humans; Male; Marijuana Abuse; Middle Aged; N-Methyl-3,4-methylenedioxyamphetamine; Narcotics; Opioid-Related Disorders; Poland; Psychotropic Drugs; Substance Abuse Treatment Centers; Substance Withdrawal Syndrome | 2004 |
Occurrence of neuronal inclusions combined with increased nigral expression of alpha-synuclein within dopaminergic neurons following treatment with amphetamine derivatives in mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenergic Uptake Inhibitors; Alkanes; alpha-Synuclein; Amides; Amphetamine; Analysis of Variance; Animals; Blotting, Western; Dopamine; Dopamine Uptake Inhibitors; Gene Expression Regulation; Glutamate Decarboxylase; Homovanillic Acid; Immunohistochemistry; Inclusion Bodies; Isoenzymes; Mice; Mice, Inbred C57BL; Microscopy, Electron, Transmission; N-Methyl-3,4-methylenedioxyamphetamine; Nerve Tissue Proteins; Neurons; Substantia Nigra; Synucleins; Tyrosine 3-Monooxygenase | 2005 |
Toxicological findings in cases of alleged drug-facilitated sexual assault in the United Kingdom over a 3-year period.
Topics: Amphetamine; Analgesics; Cannabinoids; Central Nervous System Depressants; Cocaine; Dopamine Uptake Inhibitors; Ethanol; Female; Forensic Medicine; Hallucinogens; Heroin; Humans; Hypnotics and Sedatives; Illicit Drugs; Ketamine; N-Methyl-3,4-methylenedioxyamphetamine; Pharmaceutical Preparations; Rape; Substance Abuse Detection; Time Factors; United Kingdom | 2005 |
Effects of MPEP on expression of food-, MDMA- or amphetamine-conditioned place preference in rats.
Topics: Amphetamine; Animals; Choice Behavior; Cocaine; Conditioning, Psychological; Feeding Behavior; Locomotion; Male; N-Methyl-3,4-methylenedioxyamphetamine; Pyridines; Rats; Rats, Sprague-Dawley; Reward; Serotonin Agents | 2005 |
[Rhabdomyolysis, disseminated intravascular coagulation and acute renal failure after severe narcotics intoxication (MDMA, THC, amphetamine)].
Topics: Acute Kidney Injury; Adult; Amphetamine; Central Nervous System Stimulants; Dacarbazine; Dronabinol; Hallucinogens; Humans; Male; N-Methyl-3,4-methylenedioxyamphetamine; Rhabdomyolysis | 2005 |
Serotonin-transporter mediated efflux: a pharmacological analysis of amphetamines and non-amphetamines.
Topics: Amphetamine; Biological Transport; Cell Line; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Electric Stimulation; Humans; Membrane Potentials; N-Methyl-3,4-methylenedioxyamphetamine; Patch-Clamp Techniques; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Agents; Serotonin Plasma Membrane Transport Proteins; Time Factors; Transfection; Tritium; Tyramine | 2005 |
3,4-Methylenedioxymethamphetamine enhances the release of acetylcholine in the prefrontal cortex and dorsal hippocampus of the rat.
Topics: Acetylcholine; Amphetamine; Animals; Chromatography, High Pressure Liquid; Dopamine Uptake Inhibitors; Electrochemistry; Extracellular Space; Hallucinogens; Hippocampus; Male; Microdialysis; N-Methyl-3,4-methylenedioxyamphetamine; Prefrontal Cortex; Rats; Rats, Sprague-Dawley | 2006 |
Differentiation of amphetamine/methamphetamine and other cross-immunoreactive sympathomimetic amines in urine samples by serial dilution testing.
Topics: Amphetamine; Cross Reactions; Ephedrine; Humans; Immunoassay; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; ROC Curve; Substance Abuse Detection; Sympathomimetics | 2006 |
Drug use patterns and adherence to treatment among HIV-positive patients: evidence from a large sample of French outpatients (ANRS-EN12-VESPA 2003).
Topics: Adult; Amphetamine; Antiretroviral Therapy, Highly Active; Cluster Analysis; Cocaine-Related Disorders; Cross-Sectional Studies; Female; France; Heroin Dependence; HIV Infections; Humans; Male; Marijuana Abuse; N-Methyl-3,4-methylenedioxyamphetamine; Patient Compliance; Substance Abuse, Intravenous; Surveys and Questionnaires; Tobacco Use Disorder | 2006 |
Chiral separation and quantification of R/S-amphetamine, R/S-methamphetamine, R/S-MDA, R/S-MDMA, and R/S-MDEA in whole blood by GC-EI-MS.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Chromatography, Gas; Humans; Methamphetamine; Molecular Structure; N-Methyl-3,4-methylenedioxyamphetamine; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization; Stereoisomerism; Substance Abuse Detection | 2006 |
Analysis of amphetamine, methamphetamine and methylenedioxy-methamphetamine by micellar capillary electrophoresis using cation-selective exhaustive injection.
Topics: Amphetamine; Cations; Central Nervous System Stimulants; Chromatography, Micellar Electrokinetic Capillary; Electrophoresis, Capillary; Hydrogen-Ion Concentration; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Online Systems; Reproducibility of Results; Sensitivity and Specificity; Sodium Dodecyl Sulfate | 2006 |
Rhabdomyolysis of the masseter muscle: case report.
Topics: Acute Kidney Injury; Adult; Alcoholic Intoxication; Amphetamine; Coma; Drug Overdose; Edema; Face; Humans; Male; Masseter Muscle; N-Methyl-3,4-methylenedioxyamphetamine; Rhabdomyolysis; Ultrasonography | 2008 |
The effects of price and perceived quality on the behavioural economics of alcohol, amphetamine, cannabis, cocaine, and ecstasy purchases.
Topics: Adolescent; Adult; Alcohol Drinking; Alcoholic Beverages; Amphetamine; Cannabinoids; Commerce; Consumer Behavior; Consumer Product Safety; Decision Making; England; Female; Humans; Income; Male; Motivation; N-Methyl-3,4-methylenedioxyamphetamine; Statistics as Topic; Substance-Related Disorders | 2007 |
Information processing speed in ecstasy (MDMA) users.
Topics: Adult; Amphetamine; Cannabis; Cocaine; Ethanol; Humans; Memory; Mental Processes; Multivariate Analysis; N-Methyl-3,4-methylenedioxyamphetamine; Pattern Recognition, Visual; Psychomotor Performance; Reproducibility of Results; Self Administration; Substance-Related Disorders; Surveys and Questionnaires; Time Factors | 2007 |
Time-resolved hair analysis of MDMA enantiomers by GC/MS-NCI.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Biomarkers; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Gas Chromatography-Mass Spectrometry; Hair; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Substance Abuse Detection; Time Factors | 2007 |
Assessment of cognitive brain function in ecstasy users and contributions of other drugs of abuse: results from an FMRI study.
Topics: Adolescent; Adult; Alcohol Drinking; Amphetamine; Attention; Brain; Cocaine; Cognition; Female; Humans; Magnetic Resonance Imaging; Male; Marijuana Abuse; Memory; N-Methyl-3,4-methylenedioxyamphetamine; Smoking; Substance-Related Disorders | 2008 |
Electrophysiologic changes in ventral midbrain dopaminergic neurons resulting from (+/-) -3,4-methylenedioxymethamphetamine (MDMA-"Ecstasy").
Topics: Action Potentials; Amphetamine; Animals; Autoreceptors; Carbidopa; Cocaine; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Hallucinogens; Membrane Potentials; Mesencephalon; N-Methyl-3,4-methylenedioxyamphetamine; Neural Inhibition; Neurons; Pindolol; Receptors, Dopamine D2; Ventral Tegmental Area | 2007 |
Short-term effects of 3,4-methylen-dioxy-metamphetamine (MDMA) on 5-HT(1A) receptors in the rat hippocampus.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Amphetamine; Animals; Binding Sites; Binding, Competitive; Brain Chemistry; Dopamine Agents; Guanosine 5'-O-(3-Thiotriphosphate); Hippocampus; N-Methyl-3,4-methylenedioxyamphetamine; Radioligand Assay; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1A; Serotonin; Serotonin Agents; Serotonin Plasma Membrane Transport Proteins; Synaptic Transmission; Time Factors | 2007 |
Different oxidative profile and nicotinic receptor interaction of amphetamine and 3,4-methylenedioxy-methamphetamine.
Topics: Adrenergic Uptake Inhibitors; Amphetamine; Animals; Calcium Signaling; Corpus Striatum; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Drug Synergism; Male; Mice; N-Methyl-3,4-methylenedioxyamphetamine; Neurons; Nicotinic Antagonists; Oxidation-Reduction; Oxidative Stress; PC12 Cells; Presynaptic Terminals; Rats; Reactive Oxygen Species; Receptors, Nicotinic; Subcellular Fractions; Synaptosomes | 2008 |
Specific effects of ecstasy and other illicit drugs on cognition in poly-substance users.
Topics: Adolescent; Adult; Amphetamine; Attention; Cannabis; Central Nervous System Stimulants; Cocaine; Cognition; Cognition Disorders; Female; Hallucinogens; Humans; Illicit Drugs; Male; Memory, Short-Term; N-Methyl-3,4-methylenedioxyamphetamine; Netherlands; Neuropsychological Tests; Space Perception; Substance-Related Disorders; Verbal Behavior; Visual Perception | 2008 |
Interactions between ethanol and cocaine, amphetamine, or MDMA in the rat: thermoregulatory and locomotor effects.
Topics: Amphetamine; Animals; Body Temperature Regulation; Central Nervous System Depressants; Central Nervous System Stimulants; Cocaine; Drug Interactions; Ethanol; Injections, Intraperitoneal; Male; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Long-Evans | 2008 |
Direct injection LC-MS/MS method for identification and quantification of amphetamine, methamphetamine, 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine in urine drug testing.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Chromatography, Liquid; Gas Chromatography-Mass Spectrometry; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Reproducibility of Results; Substance Abuse Detection; Tandem Mass Spectrometry | 2008 |
High ambient temperature increases intravenous methamphetamine self-administration on fixed and progressive ratio schedules in rats.
Topics: Amphetamine; Animals; Benzazepines; Body Temperature; Conditioning, Operant; Infusions, Intravenous; Male; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Wistar; Reinforcement Schedule; Self Administration; Temperature | 2008 |
The effects of perceived quality on the behavioural economics of alcohol, amphetamine, cannabis, cocaine, and ecstasy purchases.
Topics: Adult; Alcohol Drinking; Amphetamine; Catchment Area, Health; Cocaine-Related Disorders; Commerce; Comorbidity; Decision Making; Female; Humans; Male; Marijuana Abuse; Mass Screening; N-Methyl-3,4-methylenedioxyamphetamine; Prevalence; Substance-Related Disorders; Surveys and Questionnaires; United Kingdom | 2008 |
Sub-chronic nandrolone treatment modifies neurochemical and behavioral effects of amphetamine and 3,4-methylenedioxymethamphetamine (MDMA) in rats.
Topics: Adrenergic Uptake Inhibitors; Amphetamine; Anabolic Agents; Analysis of Variance; Animals; Area Under Curve; Behavior, Animal; Dopamine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Male; Microdialysis; N-Methyl-3,4-methylenedioxyamphetamine; Nandrolone; Nucleus Accumbens; Rats; Rats, Wistar; Reward; Serotonin; Statistics, Nonparametric | 2008 |
Driving under the influence of central stimulant amines: age and gender differences in concentrations of amphetamine, methamphetamine, and ecstasy in blood.
Topics: Adult; Age Factors; Amphetamine; Amphetamine-Related Disorders; Automobile Driving; Central Nervous System Stimulants; Databases, Factual; Female; Forensic Toxicology; Humans; Male; Methamphetamine; Middle Aged; N-Methyl-3,4-methylenedioxyamphetamine; Prevalence; Sex Factors; Substance Abuse Detection; Sweden | 2008 |
Elimination half-lives of benzoylecgonine and MDMA in an apprehended driver.
Topics: 3,4-Methylenedioxyamphetamine; Adult; Amphetamine; Automobile Driving; Cocaine; Forensic Toxicology; Half-Life; Hallucinogens; Humans; Male; N-Methyl-3,4-methylenedioxyamphetamine; Substance Abuse Detection | 2008 |
Modulation of glucose uptake in a human choriocarcinoma cell line (BeWo) by dietary bioactive compounds and drugs of abuse.
Topics: Acetaldehyde; Amphetamine; Biological Transport; Caffeine; Cell Line, Tumor; Cell Survival; Choriocarcinoma; Cytochalasin B; Deoxyglucose; Diet; Dronabinol; Ethanol; Flavonoids; Glucose; Humans; Illicit Drugs; Kinetics; N-Methyl-3,4-methylenedioxyamphetamine; Nicotine; Phenols; Polyphenols; Theophylline; Trophoblasts | 2008 |
Simultaneous determination of amphetamine-type stimulants and cannabinoids in fingernails by gas chromatography-mass spectrometry.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Amphetamine-Related Disorders; Amphetamines; Dronabinol; Gas Chromatography-Mass Spectrometry; Humans; Marijuana Abuse; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Nails; Observer Variation; Reproducibility of Results; Substance Abuse Detection | 2008 |
Determination of amphetamine, methamphetamine, MDA and MDMA in human hair by GC-EI-MS after derivatization with perfluorooctanoyl chloride.
Topics: Amphetamine; Caprylates; Female; Fluorocarbons; Gas Chromatography-Mass Spectrometry; Hair; Humans; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Quality Control; Regression Analysis; Reproducibility of Results; Time Factors | 2009 |
Diazatetraester 1H-pyrazole crowns as fluorescent chemosensors for AMPH, METH, MDMA (ecstasy), and dopamine.
Topics: Amphetamine; Aza Compounds; Costs and Cost Analysis; Dopamine; Esters; Fluorescent Dyes; Illicit Drugs; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Pyrazoles; Sensitivity and Specificity; Spectrometry, Fluorescence; Time Factors; Titrimetry; Water | 2008 |
Multiclass analysis of illicit drugs in plasma and oral fluids by LC-MS/MS.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Body Fluids; Calibration; Chromatography, High Pressure Liquid; Cocaine; Dronabinol; Humans; Illicit Drugs; Ketamine; Methamphetamine; Morphine; Morphine Derivatives; N-Methyl-3,4-methylenedioxyamphetamine; Phencyclidine; Sensitivity and Specificity; Tandem Mass Spectrometry; Time Factors | 2009 |
The spectroscopic detection of drugs of abuse in fingerprints after development with powders and recovery with adhesive lifters.
Topics: Amphetamine; Cocaine; Dermatoglyphics; Humans; Ketamine; Lifting; N-Methyl-3,4-methylenedioxyamphetamine; Powders; Spectrum Analysis, Raman; Substance Abuse Detection; Surgical Tape | 2009 |
Folic acid uptake by the human syncytiotrophoblast: interference by pharmacotherapy, drugs of abuse and pathological conditions.
Topics: Amphetamine; Antihypertensive Agents; Atenolol; Biological Transport; Cell Survival; Cells, Cultured; Diabetes Mellitus; Dose-Response Relationship, Drug; Dronabinol; Eclampsia; Ethanol; Female; Folic Acid; Gene Expression; Glucose; Humans; Hydrogen-Ion Concentration; Hypoglycemic Agents; Illicit Drugs; Insulin; Kinetics; Labetalol; N-Methyl-3,4-methylenedioxyamphetamine; Nicotine; Pregnancy; Trophoblasts | 2009 |
[Amphetamine and its analogues determination in urine from patients hospitalized in the Department of Toxicology Jagiellonian University Collegium Medicum in Krakow].
Topics: Amphetamine; Amphetamine-Related Disorders; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Poland; Substance Abuse Detection | 2009 |
Rapid and simple determination of psychotropic phenylalkylamine derivatives in human hair by gas chromatography-mass spectrometry using micro-pulverized extraction.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Forensic Toxicology; Gas Chromatography-Mass Spectrometry; Hair; Hallucinogens; Humans; Ketamine; Limit of Detection; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Substance Abuse Detection | 2010 |
Identification and quantitation of amphetamine, methamphetamine, MDMA, pseudoephedrine, and ephedrine in blood, plasma, and serum using gas chromatography-mass spectrometry (GC/MS).
Topics: Amphetamine; Ephedrine; Gas Chromatography-Mass Spectrometry; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Pseudoephedrine; Reproducibility of Results | 2010 |
Reinstatement of extinguished amphetamine self-administration by 3,4-methylenedioxymethamphetamine (MDMA) and its enantiomers in rhesus monkeys.
Topics: Amphetamine; Animals; Dose-Response Relationship, Drug; Female; Macaca mulatta; N-Methyl-3,4-methylenedioxyamphetamine; Reaction Time; Reinforcement Schedule; Self Administration; Stereoisomerism | 2010 |
Detection of Delta9-tetrahydrocannabinol and amphetamine-type stimulants in oral fluid using the Rapid Stat point-of-collection drug-testing device.
Topics: Amphetamine; Amphetamine-Related Disorders; Amphetamines; Dronabinol; False Negative Reactions; False Positive Reactions; Gas Chromatography-Mass Spectrometry; Humans; Immunoassay; Marijuana Abuse; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Predictive Value of Tests; Saliva; Sensitivity and Specificity; Solid Phase Extraction; Substance Abuse Detection | 2010 |
Estimation of illicit drugs consumption by wastewater analysis in Paris area (France).
Topics: Amphetamine; Buprenorphine; Chromatography, High Pressure Liquid; Cocaine; Humans; Illicit Drugs; Mass Spectrometry; N-Methyl-3,4-methylenedioxyamphetamine; Paris; Sewage | 2010 |
Evaluation of drugs of abuse use and trends in a prison through wastewater analysis.
Topics: Alprazolam; Amphetamine; Cannabinoids; Cocaine; Environmental Monitoring; Ephedrine; Heroin; Humans; Illicit Drugs; Methadone; N-Methyl-3,4-methylenedioxyamphetamine; Prisons; Sewage; Substance Abuse Detection; Water Pollutants, Chemical; Water Pollution, Chemical | 2011 |
Illicit drugs in Canadian municipal wastewater and estimates of community drug use.
Topics: Amphetamine; Canada; Cities; Cocaine; Illicit Drugs; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Solid Phase Extraction; Substance Abuse Detection; Substance-Related Disorders; Waste Disposal, Fluid; Water Pollutants, Chemical; Water Pollution, Chemical | 2010 |
Comparison of (+)-methamphetamine, ±-methylenedioxymethamphetamine, (+)-amphetamine and ±-fenfluramine in rats on egocentric learning in the Cincinnati water maze.
Topics: Amphetamine; Analysis of Variance; Animals; Behavior, Animal; Body Temperature; Body Weight; Central Nervous System Stimulants; Cold Temperature; Fenfluramine; Male; Maze Learning; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley; Serotonin Agents; Spatial Behavior; Swimming; Time Factors | 2011 |
Medial prefrontal gray matter volume reductions in users of amphetamine-type stimulants revealed by combined tract-based spatial statistics and voxel-based morphometry.
Topics: Adrenergic Uptake Inhibitors; Adult; Amphetamine; Amphetamines; Diffusion Magnetic Resonance Imaging; Female; Humans; Illicit Drugs; Image Processing, Computer-Assisted; Male; N-Methyl-3,4-methylenedioxyamphetamine; Prefrontal Cortex | 2011 |
Instability of the ecstasy market and a new kid on the block: mephedrone.
Topics: Amphetamine; Humans; Illicit Drugs; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Netherlands; Tablets | 2011 |
Mortality among individuals with cannabis, cocaine, amphetamine, MDMA, and opioid use disorders: a nationwide follow-up study of Danish substance users in treatment.
Topics: Adult; Amphetamine; Analgesics, Opioid; Cannabis; Cocaine; Cohort Studies; Denmark; Female; Follow-Up Studies; Humans; Male; Marijuana Abuse; N-Methyl-3,4-methylenedioxyamphetamine; Opioid-Related Disorders; Registries; Substance-Related Disorders; Treatment Outcome; Young Adult | 2011 |
Examining the role of oxytocin in the interoceptive effects of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') using a drug discrimination paradigm in the rat.
Topics: Adrenergic Uptake Inhibitors; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Amphetamine; Amphetamine-Related Disorders; Animals; Antidepressive Agents, Tricyclic; Brain; Conditioning, Psychological; Cues; Discrimination Learning; Excitatory Amino Acid Antagonists; Female; Hormone Antagonists; Imipramine; Male; Motivation; N-Methyl-3,4-methylenedioxyamphetamine; Oxytocin; Rats; Rats, Sprague-Dawley; Receptors, Oxytocin; Synaptic Transmission; Vasotocin | 2011 |
Detection of phentermine in hair samples from drug suspects.
Topics: Adult; Amphetamine; Central Nervous System Stimulants; Female; Forensic Toxicology; Gas Chromatography-Mass Spectrometry; Hair; Humans; Male; Methamphetamine; Middle Aged; N-Methyl-3,4-methylenedioxyamphetamine; Phentermine; Substance Abuse Detection; Substance-Related Disorders | 2011 |
Differences in binding affinities of MDA, MDMA, MDEA, Amphetamine, Methamphetamine, and their deuterated analogues to solid-phase extraction cartridges.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Deuterium; Gas Chromatography-Mass Spectrometry; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Solid Phase Extraction; Substance Abuse Detection | 2011 |
Urine analysis of 3,4-methylenedioxypyrovalerone in opioid-dependent patients by gas chromatography-mass spectrometry.
Topics: Adult; Amphetamine; Benzodioxoles; Designer Drugs; Female; Gas Chromatography-Mass Spectrometry; Humans; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Opiate Substitution Treatment; Opioid-Related Disorders; Psychotropic Drugs; Pyrrolidines; Substance Abuse Detection; Synthetic Cathinone | 2011 |
Amphetamine-associated seizures: clinical features and prognosis.
Topics: Adolescent; Adult; Amphetamine; Anticonvulsants; Central Nervous System Stimulants; Electroencephalography; Female; Follow-Up Studies; Hallucinogens; Humans; Illicit Drugs; Kaplan-Meier Estimate; Male; N-Methyl-3,4-methylenedioxyamphetamine; Prognosis; Recurrence; Risk Factors; Seizures; Status Epilepticus; Western Australia; Young Adult | 2011 |
Mephedrone, compared with MDMA (ecstasy) and amphetamine, rapidly increases both dopamine and 5-HT levels in nucleus accumbens of awake rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamine; Animals; Chromatography, High Pressure Liquid; Dopamine; Hydroxyindoleacetic Acid; Locomotion; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Serotonin | 2011 |
Methamphetamine, amphetamine, MDMA ('ecstasy'), MDA and mCPP modulate electrical and cholinergic input in PC12 cells.
Topics: 3,4-Methylenedioxyamphetamine; Adrenergic Agents; Amphetamine; Animals; Calcium; Cholinergic Agents; Dose-Response Relationship, Drug; Membrane Potentials; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; PC12 Cells; Piperazines; Potassium Chloride; Rats; Serotonin Receptor Agonists | 2012 |
[A new designer drug: methylone related death].
Topics: Adolescent; Amphetamine; Asthma; Autopsy; Causality; Death, Sudden, Cardiac; Designer Drugs; Drug Overdose; Fatal Outcome; Fatty Liver; Heart Defects, Congenital; Humans; Hungary; Male; Methamphetamine; Muscle, Smooth; N-Methyl-3,4-methylenedioxyamphetamine | 2012 |
[The phenomenon of drug change in the interviews with injecting drug users].
Topics: Adolescent; Adult; Amphetamine; Cocaine; Cocaine-Related Disorders; Designer Drugs; Dopamine Uptake Inhibitors; Drug Users; Female; Heroin; Humans; Hungary; Illicit Drugs; Interview, Psychological; Male; Methamphetamine; Middle Aged; N-Methyl-3,4-methylenedioxyamphetamine; Narcotics; Narration; Needle-Exchange Programs; Risk-Taking; Substance Abuse, Intravenous; Young Adult | 2012 |
Evaluation of pre-analysis loss of dependent drugs in wastewater: stability and binding assessments.
Topics: Amphetamine; Chromatography, Liquid; Cocaine; Codeine; Cotinine; Drug Stability; Illicit Drugs; Liquid-Liquid Extraction; Methamphetamine; Morphine; Morphine Derivatives; N-Methyl-3,4-methylenedioxyamphetamine; Tandem Mass Spectrometry; Wastewater; Water Pollutants, Chemical | 2013 |
Do prenatally methamphetamine-exposed adult male rats display general predisposition to drug abuse in the conditioned place preference test?
Topics: Amphetamine; Animals; Behavior, Animal; Central Nervous System Stimulants; Conditioning, Psychological; Disease Susceptibility; Female; Humans; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Wistar; Substance-Related Disorders | 2012 |
Behavioral and antinociceptive effects of different psychostimulant drugs in prenatally methamphetamine-exposed rats.
Topics: Amphetamine; Animals; Behavior, Animal; Central Nervous System Stimulants; Cocaine; Female; Male; Methamphetamine; Morphine; N-Methyl-3,4-methylenedioxyamphetamine; Narcotics; Pregnancy; Prenatal Exposure Delayed Effects; Rats | 2012 |
Mephedrone does not damage dopamine nerve endings of the striatum, but enhances the neurotoxicity of methamphetamine, amphetamine, and MDMA.
Topics: Amphetamine; Animals; Corpus Striatum; Dopamine; Drug Synergism; Female; Fever; Methamphetamine; Mice; Mice, Inbred C57BL; N-Methyl-3,4-methylenedioxyamphetamine; Nerve Endings; Psychotropic Drugs | 2013 |
The nucleus accumbens 5-HTR₄-CART pathway ties anorexia to hyperactivity.
Topics: Amphetamine; Animals; Anorexia; Cocaine; Hyperkinesis; Male; Mice; Mice, Knockout; N-Methyl-3,4-methylenedioxyamphetamine; Nucleus Accumbens; Piperidines; Propane; Real-Time Polymerase Chain Reaction; Receptors, Serotonin, 5-HT4; Serotonin 5-HT4 Receptor Antagonists | 2012 |
In-sample derivatization-solid-phase microextraction of amphetamines and ecstasy related stimulants from water and urine.
Topics: Amphetamine; Gas Chromatography-Mass Spectrometry; Humans; Limit of Detection; Molecular Structure; N-Methyl-3,4-methylenedioxyamphetamine; Reference Standards; Rivers; Solid Phase Microextraction; Water Pollutants, Chemical | 2013 |
Concentrations of drugs determined in blood samples collected from suspected drugged drivers in England and Wales.
Topics: Adolescent; Adult; Amphetamine; Automobile Driving; Central Nervous System Depressants; Chromatography, Liquid; Cocaine; Diazepam; England; Ethanol; Female; Forensic Toxicology; Gas Chromatography-Mass Spectrometry; Humans; Ketamine; Male; Methadone; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Narcotics; Nordazepam; Sodium Oxybate; Substance Abuse Detection; Substance-Related Disorders; Wales; Young Adult | 2013 |
A field test of substance use screening devices as part of routine drunk-driving spot detection operating procedures in South Africa.
Topics: Adolescent; Adult; Alcohol Drinking; Alcoholic Intoxication; Amphetamine; Automobile Driving; Breath Tests; Chromatography, Liquid; Cocaine; Dronabinol; Ethanol; Female; Gas Chromatography-Mass Spectrometry; Humans; Illicit Drugs; Male; Mass Spectrometry; Methamphetamine; Middle Aged; Morphine; N-Methyl-3,4-methylenedioxyamphetamine; Pilot Projects; Saliva; South Africa; Substance Abuse Detection; Young Adult | 2013 |
Direct and long-lasting effects elicited by repeated drug administration on 50-kHz ultrasonic vocalizations are regulated differently: implications for the study of the affective properties of drugs of abuse.
Topics: Amphetamine; Animals; Central Nervous System Stimulants; Drug Administration Schedule; Male; Morphine; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Nicotine; Psychotropic Drugs; Rats; Rats, Sprague-Dawley; Time Factors; Ultrasonics; Vocalization, Animal | 2014 |
Modeling chronic brain exposure to amphetamines using primary rat neuronal cortical cultures.
Topics: Adrenergic Uptake Inhibitors; Amphetamine; Animals; Astrocytes; Caspase 3; Cell Count; Cell Culture Techniques; Cell Death; Cells, Cultured; Cerebral Cortex; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Glutathione; Mitochondria; N-Methyl-3,4-methylenedioxyamphetamine; Neurons; Rats, Wistar; Receptors, Glutamate; Time Factors | 2014 |
Effects of psychostimulants on social interaction in adult male rats.
Topics: Amphetamine; Animals; Behavior, Animal; Central Nervous System Stimulants; Cocaine; Dose-Response Relationship, Drug; Interpersonal Relations; Locomotion; Male; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Wistar | 2015 |
Recreational phenethylamine poisonings reported to a French poison control center.
Topics: Adolescent; Adult; Alkaloids; Amphetamine; Cannabis; Child; Drug Interactions; Ethanol; Female; France; Hospitalization; Humans; Intensive Care Units; Male; Methamphetamine; Middle Aged; N-Methyl-3,4-methylenedioxyamphetamine; Phenethylamines; Poison Control Centers; Prevalence; Retrospective Studies; Symptom Assessment; Young Adult | 2015 |
Wastewater-Based Epidemiology of Stimulant Drugs: Functional Data Analysis Compared to Traditional Statistical Methods.
Topics: Amphetamine; Cities; Environmental Monitoring; Epidemiological Monitoring; Europe; Humans; Illicit Drugs; Linear Models; N-Methyl-3,4-methylenedioxyamphetamine; Principal Component Analysis; Reproducibility of Results; Sewage; Substance Abuse Detection; Substance-Related Disorders; Wastewater; Water Pollutants, Chemical | 2015 |
Differential effects of 3,4-methylenedioxypyrovalerone (MDPV) and 4-methylmethcathinone (mephedrone) in rats trained to discriminate MDMA or a d-amphetamine + MDMA mixture.
Topics: Amphetamine; Animals; Benzodioxoles; Central Nervous System Stimulants; Cocaine; Dextroamphetamine; Discrimination Learning; Dose-Response Relationship, Drug; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Pyrrolidines; Rats; Rats, Sprague-Dawley; Synthetic Cathinone | 2016 |
A Retrospective Analysis of Urine Drugs of Abuse Immunoassay True Positive Rates at a National Reference Laboratory.
Topics: Adult; Amphetamine; Chromatography, Liquid; Cocaine; Dronabinol; Ethanol; False Negative Reactions; False Positive Reactions; Female; Gas Chromatography-Mass Spectrometry; Humans; Illicit Drugs; Immunoassay; Male; Methamphetamine; Middle Aged; N-Methyl-3,4-methylenedioxyamphetamine; Oxycodone; Retrospective Studies; Substance Abuse Detection; Young Adult | 2016 |
History of Illicit Stimulant Use Is Not Associated with Long-Lasting Changes in Learning of Fine Motor Skills in Humans.
Topics: Adolescent; Adult; Amphetamine; Female; Humans; Learning; Male; Motor Skills; N-Methyl-3,4-methylenedioxyamphetamine; Substance-Related Disorders; Young Adult | 2016 |
Drug testing in Europe: monitoring results of the Trans European Drug Information (TEDI) project.
Topics: Adult; Amphetamine; Cocaine; Drug Contamination; Drug Users; Europe; Humans; Illicit Drugs; Male; N-Methyl-3,4-methylenedioxyamphetamine; Powders; Psychotropic Drugs; Substance Abuse Detection; Substance-Related Disorders; Tablets | 2017 |
Determination of amphetamines in hair by integrating sample disruption, clean-up and solid phase derivatization.
Topics: Amphetamine; Amphetamines; Chromatography, Liquid; Ephedrine; Fluorenes; Fluorescent Dyes; Hair; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine | 2016 |
Enantioselective degradation of amphetamine-like environmental micropollutants (amphetamine, methamphetamine, MDMA and MDA) in urban water.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Biodegradation, Environmental; Kinetics; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Photochemical Processes; Rivers; Sewage; Stereoisomerism; Wastewater; Water; Water Microbiology | 2016 |
[Accidental amphetamine poisoning in an 11-month-old boy].
Topics: Accidents, Home; Akathisia, Drug-Induced; Amphetamine; Humans; Infant; Male; Mydriasis; N-Methyl-3,4-methylenedioxyamphetamine; Narcotics; Nystagmus, Pathologic; Tablets | 2016 |
Comparative effects of amphetamine-like psychostimulants on rat hippocampal cell genesis at different developmental ages.
Topics: Age Factors; Aging; Amphetamine; Animals; Brain-Derived Neurotrophic Factor; Bromodeoxyuridine; Central Nervous System Stimulants; Dextroamphetamine; Dose-Response Relationship, Drug; Gene Expression Regulation, Developmental; Hippocampus; Ki-67 Antigen; Male; N-Methyl-3,4-methylenedioxyamphetamine; Neurogenesis; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2C | 2016 |
ELISA Detection of 30 New Amphetamine Designer Drugs in Whole Blood, Urine and Oral Fluid using Neogen® "Amphetamine" and "Methamphetamine/MDMA" Kits.
Topics: Amphetamine; Blood; Enzyme-Linked Immunosorbent Assay; Humans; Illicit Drugs; N-Methyl-3,4-methylenedioxyamphetamine; Saliva; Substance Abuse Detection; Urine | 2016 |
Definitive Drug and Metabolite Screening in Urine by UPLC-MS-MS Using a Novel Calibration Technique.
Topics: Amphetamine; Benzodiazepines; Buprenorphine; Calibration; Chromatography, High Pressure Liquid; Cocaine; Humans; Limit of Detection; N-Methyl-3,4-methylenedioxyamphetamine; Opiate Alkaloids; Oxycodone; Phencyclidine; Reproducibility of Results; Substance Abuse Detection; Tandem Mass Spectrometry | 2016 |
Refining correction factors for back-calculation of illicit drug use.
Topics: Amphetamine; Dronabinol; Humans; Illicit Drugs; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Reproducibility of Results; Substance Abuse Detection; Wastewater | 2016 |
Decoding the Structure of Abuse Potential for New Psychoactive Substances: Structure-Activity Relationships for Abuse-Related Effects of 4-Substituted Methcathinone Analogs.
Topics: Amphetamine; Animals; Behavior, Animal; Dopamine Plasma Membrane Transport Proteins; Fenfluramine; Humans; Methamphetamine; Methylamines; N-Methyl-3,4-methylenedioxyamphetamine; Norepinephrine Plasma Membrane Transport Proteins; Propiophenones; Psychotropic Drugs; Quantitative Structure-Activity Relationship; Rats; Self Administration; Serotonin Plasma Membrane Transport Proteins; Structure-Activity Relationship; Substance-Related Disorders | 2017 |
Purity, adulteration and price of drugs bought on-line versus off-line in the Netherlands.
Topics: Amphetamine; Amphetamines; Benzofurans; Central Nervous System Stimulants; Cocaine; Cyclohexanones; Cyclohexylamines; Dimethoxyphenylethylamine; Drug Contamination; Drug Costs; Drug Trafficking; Hallucinogens; Humans; Illicit Drugs; Internet; Lysergic Acid Diethylamide; N-Methyl-3,4-methylenedioxyamphetamine; Netherlands; Propylamines | 2017 |
Psychomotor Tremor and Proprioceptive Control Problems in Current and Former Stimulant Drug Users: An Accelerometer Study of Heavy Users of Amphetamine, MDMA, and Other Recreational Stimulants.
Topics: Accelerometry; Adult; Amphetamine; Arm; Central Nervous System Stimulants; Drug Users; Female; Humans; Male; Middle Aged; N-Methyl-3,4-methylenedioxyamphetamine; Substance-Related Disorders; Tremor; Young Adult | 2017 |
A Longitudinal Study of Self-Reported Psychopathology in Beginning Ecstasy and Amphetamine Users: A Third Follow-up Evaluation.
Topics: Adolescent; Adult; Amphetamine; Amphetamine-Related Disorders; Female; Follow-Up Studies; Hallucinogens; Humans; Longitudinal Studies; Male; Mental Disorders; N-Methyl-3,4-methylenedioxyamphetamine; Self Report; Surveys and Questionnaires; Young Adult | 2017 |
Illicit drug consumption in school populations measured by wastewater analysis.
Topics: Amphetamine; Cannabinoids; Cannabis; Cocaine; Humans; Illicit Drugs; Italy; Ketamine; Mass Spectrometry; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Substance Abuse Detection; Substance-Related Disorders; Wastewater | 2017 |
Recreational drug use at a major music festival: trend analysis of anonymised pooled urine.
Topics: Adolescent; Adult; Amphetamine; Chromatography, High Pressure Liquid; Cocaine; Cross-Sectional Studies; Denmark; Dronabinol; Female; Holidays; Humans; Illicit Drugs; Immunoassay; Ketamine; Male; Mass Spectrometry; Music; N-Methyl-3,4-methylenedioxyamphetamine; Substance Abuse Detection; Substance-Related Disorders; Young Adult | 2018 |
Discriminative stimulus and locomotor effects of para-substituted and benzofuran analogs of amphetamine.
Topics: Amphetamine; Amphetamines; Animals; Benzofurans; Central Nervous System Stimulants; Cocaine; Discrimination Learning; Dose-Response Relationship, Drug; Locomotion; Male; Methamphetamine; Mice; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley | 2017 |
Commercial herbal medicines used as African traditional medicines: Ngoma Herbal Tonic Immune Booster interferes with a rapid urine drug screening test.
Topics: Amphetamine; Cocaine; Dronabinol; False Negative Reactions; False Positive Reactions; Humans; Medicine, African Traditional; Methamphetamine; Morphine; N-Methyl-3,4-methylenedioxyamphetamine; Plant Preparations; Substance Abuse Detection | 2017 |
Cross-reactivity of selected benzofurans with commercial amphetamine and ecstasy immunoassays in urine.
Topics: Amphetamine; Benzofurans; Cross Reactions; Gas Chromatography-Mass Spectrometry; Humans; Immunoassay; N-Methyl-3,4-methylenedioxyamphetamine; Substance Abuse Detection | 2017 |
Intermolecular interactions between DNA and methamphetamine, amphetamine, ecstasy and their major metabolites.
Topics: Amphetamine; Central Nervous System Stimulants; DNA; Humans; Methamphetamine; Molecular Docking Simulation; N-Methyl-3,4-methylenedioxyamphetamine | 2018 |
Estimation of the consumption of illicit drugs during special events in two communities in Western Kentucky, USA using sewage epidemiology.
Topics: Amphetamine; Anniversaries and Special Events; Cocaine; Environmental Monitoring; Humans; Illicit Drugs; Kentucky; N-Methyl-3,4-methylenedioxyamphetamine; Sewage; Substance Abuse Detection; Substance-Related Disorders; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical; Water Pollution, Chemical | 2018 |
Typology of new psychoactive substance use among the general Australian population.
Topics: Adolescent; Adult; Amphetamine; Australia; Cannabinoids; Cannabis; Cocaine; Female; Humans; Illicit Drugs; Male; N-Methyl-3,4-methylenedioxyamphetamine; Population Surveillance; Psychotropic Drugs; Substance-Related Disorders; Young Adult | 2018 |
Dopamine and serotonin antagonists fail to alter the discriminative stimulus properties of ±methylenedioxymethamphetamine.
Topics: Amphetamine; Animals; Discrimination Learning; Dopamine; Dopamine Antagonists; Dopaminergic Neurons; Dose-Response Relationship, Drug; Male; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley; Serotonergic Neurons; Serotonin; Serotonin Antagonists | 2019 |
Postmortem Brain-Blood Ratios of Amphetamine, Cocaine, Ephedrine, MDMA and Methylphenidate.
Topics: Amphetamine; Autopsy; Brain Chemistry; Calibration; Cocaine; Forensic Toxicology; Gray Matter; Humans; Methylphenidate; N-Methyl-3,4-methylenedioxyamphetamine; Postmortem Changes; Reference Standards; Reproducibility of Results | 2019 |
False positive amphetamines and 3,4-methylenedioxymethamphetamine immunoassays in the presence of metoprolol-two cases reported in clinical toxicology.
Topics: Adult; Amphetamine; Amphetamines; Cross Reactions; Female; Forensic Toxicology; Gas Chromatography-Mass Spectrometry; Humans; Immunoassay; Immunoenzyme Techniques; Male; Methamphetamine; Metoprolol; Middle Aged; N-Methyl-3,4-methylenedioxyamphetamine; Substance Abuse Detection | 2020 |
Quantitative Estimation of 38 Illicit Psychostimulants in Blood by GC-APCI-QTOFMS with Nitrogen Chemiluminescence Detection Based on Three External Calibrators.
Topics: Amphetamine; Benzodioxoles; Calibration; Central Nervous System Stimulants; Gas Chromatography-Mass Spectrometry; Humans; Illicit Drugs; Luminescence; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Nitrogen; Pyrrolidines; Substance Abuse Detection; Synthetic Cathinone | 2020 |
A comparison of trends in wastewater-based data and traditional epidemiological indicators of stimulant consumption in three locations.
Topics: Amphetamine; Cocaine; Data Collection; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Netherlands; Norway; Queensland; Substance Abuse Detection; Wastewater; Wastewater-Based Epidemiological Monitoring | 2020 |
Spatio-temporal assessment of illicit drug use at large scale: evidence from 7 years of international wastewater monitoring.
Topics: Amphetamine; Chromatography, Liquid; Cocaine; Environmental Monitoring; Humans; Illicit Drugs; Internationality; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Spatio-Temporal Analysis; Substance Abuse Detection; Tandem Mass Spectrometry; Wastewater | 2020 |
[High-risk drug use: epidemiological pattern through hair testing in the forensic context].
Topics: 3,4-Methylenedioxyamphetamine; Adolescent; Adult; Amphetamine; Cannabinoids; Cocaine; Cross-Sectional Studies; Female; Forensic Sciences; Gas Chromatography-Mass Spectrometry; Hair; Heroin; Humans; Illicit Drugs; Ketamine; Male; Methadone; Methamphetamine; Middle Aged; N-Methyl-3,4-methylenedioxyamphetamine; Prevalence; Spain; Substance Abuse Detection; Substance-Related Disorders; Young Adult | 2019 |
Stability and Degradation Pathways of Different Psychoactive Drugs in Neat and in Buffered Oral Fluid.
Topics: Amphetamine; Cocaine; Codeine; Drug Stability; Forensic Toxicology; Illicit Drugs; Methamphetamine; Morphine; Morphine Derivatives; N-Methyl-3,4-methylenedioxyamphetamine; Psychotropic Drugs; Specimen Handling; Substance Abuse Detection | 2020 |
MDMA Intoxication in a Potential Organ Donor with Cardiac Arrest.
Topics: 3,4-Methylenedioxyamphetamine; Adolescent; Amphetamine; Drug Overdose; Forensic Medicine; Gas Chromatography-Mass Spectrometry; Hallucinogens; Heart Arrest; Humans; Male; N-Methyl-3,4-methylenedioxyamphetamine; Substance Abuse Detection; Tissue Donors | 2020 |
Methamphetamine, Amphetamine, and MDMA Use and Emergency Department Recidivism.
Topics: Adult; Amphetamine; Emergency Service, Hospital; Female; Humans; Male; Methamphetamine; Middle Aged; N-Methyl-3,4-methylenedioxyamphetamine; Recidivism; Retrospective Studies | 2020 |
Urine drug-testing tampering approaches: Turkish probationers.
Topics: Acetic Acid; Amphetamine; Bleaching Agents; Carbonates; Creatinine; Dronabinol; Drug Contamination; False Negative Reactions; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Ophthalmic Solutions; Reagent Strips; Sodium Hydroxide; Substance Abuse Detection; Turkey | 2021 |
Stimulant storm - state health department psychostimulant age-adjusted mortality rate correlates with psychostimulant-based Michigan Poison Center case exposures over time.
Topics: Adult; Amphetamine; Central Nervous System Stimulants; Dextroamphetamine; Drug Overdose; Female; Humans; Linear Models; Male; Methamphetamine; Methylphenidate; Michigan; N-Methyl-3,4-methylenedioxyamphetamine; Opioid-Related Disorders; Poison Control Centers | 2021 |
Determination of the enantiomeric composition of amphetamine, methamphetamine and 3,4-methylendioxy-N-methylamphetamine (MDMA) in seized street drug samples from southern Germany.
Topics: Amphetamine; Illicit Drugs; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Stereoisomerism | 2022 |
Retrospective suspect and non-target screening combined with similarity measures to prioritize MDMA and amphetamine synthesis markers in wastewater.
Topics: Amphetamine; Chromatography, Liquid; N-Methyl-3,4-methylenedioxyamphetamine; Retrospective Studies; Substance Abuse Detection; Wastewater | 2022 |
Prevalence of cathinones and other new psychoactive substances in hair of parents and children of families with known or suspected parental abuse of conventional illegal drugs.
Topics: Adolescent; Adult; Alkaloids; Amphetamine; Benzodiazepines; Central Nervous System Agents; Child; Child, Preschool; Chromatography, Liquid; Cocaine; Heroin; Humans; Illicit Drugs; Infant; N-Methyl-3,4-methylenedioxyamphetamine; Parents; Plant Extracts; Prevalence; Psychotropic Drugs; Substance Abuse Detection; Tandem Mass Spectrometry | 2022 |
Qualitative Screening of Amphetamine- and Ketamine-Type Abuse Drugs in Urine Employing Dual Mode Extraction Column by Liquid Chromatography-Tandem Mass Spectrometry (LC-MS-MS).
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Chromatography, Liquid; Ephedrine; Humans; Illicit Drugs; Ketamine; N-Methyl-3,4-methylenedioxyamphetamine; Polymethyl Methacrylate; Pseudoephedrine; Substance Abuse Detection; Substance-Related Disorders; Tandem Mass Spectrometry | 2023 |
Pharmacological characterization of 3,4-methylenedioxyamphetamine (MDA) analogs and two amphetamine-based compounds: N,α-DEPEA and DPIA.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Carrier Proteins; Dopamine; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Serotonin | 2022 |
Enantiomeric profiling of amphetamines in wastewater using chiral derivatisation with gas chromatographic-tandem mass spectrometric detection.
Topics: Amphetamine; Amphetamines; Gas Chromatography-Mass Spectrometry; Illicit Drugs; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Substance Abuse Detection; Tandem Mass Spectrometry; Wastewater; Water Pollutants, Chemical | 2022 |
Use of illicit drugs, alcohol and tobacco in Spain and Portugal during the COVID-19 crisis in 2020 as measured by wastewater-based epidemiology.
Topics: Amphetamine; Cocaine; Communicable Disease Control; COVID-19; Humans; Illicit Drugs; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Nicotiana; Pandemics; Portugal; Spain; Substance Abuse Detection; Substance-Related Disorders; Wastewater; Wastewater-Based Epidemiological Monitoring; Water Pollutants, Chemical | 2022 |
Long-term monitoring of drug consumption patterns during the COVID-19 pandemic in a small-sized community in Brazil through wastewater-based epidemiology.
Topics: Amphetamine; Brazil; Caffeine; Cocaine; COVID-19; Dronabinol; Humans; Illicit Drugs; N-Methyl-3,4-methylenedioxyamphetamine; Nicotine; Pandemics; Substance Abuse Detection; Substance-Related Disorders; Wastewater; Wastewater-Based Epidemiological Monitoring; Water Pollutants, Chemical | 2022 |
Monitoring of changes in illicit drugs, alcohol, and nicotine consumption during Ramadan via wastewater analysis.
Topics: Amphetamine; Cannabis; Cocaine; Ethanol; Heroin; Humans; Illicit Drugs; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Nicotine; Substance Abuse Detection; Wastewater; Water Pollutants, Chemical | 2022 |
Common opioids and stimulants in autopsy and DUID cases: A comparison of measured concentrations.
Topics: Amphetamine; Analgesics, Opioid; Autopsy; Central Nervous System Stimulants; Cocaine; Coma; Heroin; Humans; Methadone; Morphine; N-Methyl-3,4-methylenedioxyamphetamine; Substance Abuse Detection; Substance-Related Disorders | 2022 |
Combined Use of Flubromazepam and Stimulants: Blood and Oral Fluid Concentrations and Impact on Driving Ability.
Topics: Amphetamine; Benzodiazepines; Central Nervous System Stimulants; Humans; Male; N-Methyl-3,4-methylenedioxyamphetamine; Substance Abuse Detection | 2023 |
Wastewater-based monitoring of illicit drugs in Cyprus by UPLC-MS/MS: The impact of the COVID-19 pandemic.
Topics: Amphetamine; Chromatography, Liquid; Cocaine; Communicable Disease Control; COVID-19; Cyprus; Humans; Illicit Drugs; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Pandemics; Substance Abuse Detection; Substance-Related Disorders; Tandem Mass Spectrometry; Wastewater; Water Pollutants, Chemical | 2023 |
False-Positive Amphetamines in Urine Drug Screens: A 6-Year Review.
Topics: Amphetamine; Amphetamines; Immunoassay; Mass Spectrometry; N-Methyl-3,4-methylenedioxyamphetamine; Substance Abuse Detection | 2023 |
Pulverization Is a Crucial Step-A Comparative Study of Different Pretreatments in Hair Drug Testing.
Topics: Amphetamine; Hair; Illicit Drugs; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Substance Abuse Detection | 2023 |
An overview of New Psychoactive Substances (NPS) in northeast Brazil: NMR-based identification and analysis of ecstasy tablets by GC-MS.
Topics: Amphetamine; Brazil; Central Nervous System Stimulants; Gas Chromatography-Mass Spectrometry; Illicit Drugs; N-Methyl-3,4-methylenedioxyamphetamine; Psychotropic Drugs; Synthetic Drugs; Tablets | 2023 |
Long-term wastewater-based surveillance and impacts of the COVID-19 pandemic on drug use trends in a U.S. Northeast rural town.
Topics: Amphetamine; Cocaine; COVID-19; Fentanyl; Humans; Hydrocodone; Methadone; N-Methyl-3,4-methylenedioxyamphetamine; Pandemics; Rural Population; Substance Abuse Detection; Substance-Related Disorders; Wastewater; Wastewater-Based Epidemiological Monitoring; Water Pollutants, Chemical | 2023 |
Estimation of legal and illegal drugs consumption in Valencia City (Spain): 10 years of monitoring.
Topics: Amphetamine; Cocaine; Illicit Drugs; N-Methyl-3,4-methylenedioxyamphetamine; Sewage; Spain; Water Pollutants, Chemical | 2023 |
Assessing the impact of a major electronic music festival on the consumption patterns of illicit and licit psychoactive substances in a Mediterranean city using wastewater analysis.
Topics: Amphetamine; Analgesics, Opioid; Cocaine; Ethanol; Heroin; Holidays; Humans; Illicit Drugs; Music; N-Methyl-3,4-methylenedioxyamphetamine; Nicotine; Substance Abuse Detection; Substance-Related Disorders; Wastewater; Water Pollutants, Chemical | 2023 |
Concomitant Drug Use among Opioid-Dependent Patients with and without Attention Deficit Hyperactivity Disorder: Does Methylphenidate Merit a Trial?
Topics: Amphetamine; Analgesics, Opioid; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Cocaine; Cocaine-Related Disorders; Cross-Sectional Studies; Heroin; Humans; Methylphenidate; N-Methyl-3,4-methylenedioxyamphetamine; Substance-Related Disorders; Treatment Outcome | 2023 |
Trends in drivers testing positive for drugs of abuse in oral fluid from 2018 to 2021 in France.
Topics: Adolescent; Adult; Aged; Amphetamine; Automobile Driving; Cannabinoid Receptor Agonists; Chromatography, Liquid; Cocaine; Female; Hallucinogens; Humans; Illicit Drugs; Male; Middle Aged; N-Methyl-3,4-methylenedioxyamphetamine; Saliva; Substance Abuse Detection; Substance-Related Disorders; Tandem Mass Spectrometry; Young Adult | 2023 |
Comprehensive evaluation of drug cases in Seoul and its metropolitan areas - 2022.
Topics: Amphetamine; Cannabinoids; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Seoul; Substance Abuse Detection | 2023 |
First drug-checking study at an electronic festival and fentanyl detection in the central region of Mexico.
Topics: Amphetamine; Female; Fentanyl; Holidays; Humans; Illicit Drugs; Male; Mexico; N-Methyl-3,4-methylenedioxyamphetamine; Venlafaxine Hydrochloride | 2023 |